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Summary 
In the peripheral nervous system (PNS) Schwann cells (SC) engulf, insulate and support 
motor and sensory axons. Nonmyelinating SC are associated with axons smaller than 1 µm 
in diameter, whereas myelinating SC form a compact myelin sheath around axons larger 
than 1 µm in diameter to enable rapid saltatory impulse propagation. During peripheral nerve 
regeneration motor and sensory SC express distinct trophic factors and extracellular matrix 
components to allow appropriate reinnervation. This implies that motor and sensory SC 
display a differential molecular architecture also in the intact PNS. It was unknown if 
differences exist with regard to the myelin sheath. Therefore, this study first aimed to identify 
differences between motor and sensory SC with respect to their myelin sheath composition. 
For this purpose, comparative proteome analyses of dorsal and ventral root myelin were 
performed. Numerous differences in the molecular myelin constitution, beyond the differential 
expression of classical myelin proteins, were observed. In particular, the noncompact myelin 
protein 2’,3’-cyclic nucleotide 3-phosphodiesterase (CNP) displayed substantially higher 
expression levels in dorsal compared to ventral roots. This suggests a differential impact of 
CNP for motor and sensory fibers. In the central nervous system (CNS) CNP is involved in 
axonal support independent of myelination and its deficiency causes a severe 
neurodegeneration. Hence, this study further aimed to uncover the role of CNP in the PNS 
and its importance for different fiber types. Immunostainings revealed that CNP is enriched in 
myelinating SC that ensheath small caliber motor and sensory axons. As in the CNS, CNP 
ablation caused a reduction in size of the noncompacted myelin compartment. Moreover, 
CNP deficient mice exhibited an adult onset hypermyelination of small caliber peripheral 
nerve fibers. In order to understand the underlying mechanism of continued myelination, 
MAPK/ERK and PI3K/AKT signaling pathways were investigated. Surprisingly, the activities 
of both pathways increased in the absence of CNP, suggesting that CNP is a negative 
regulator of both pathways in mature nerves. Together, CNP deficiency caused a remarkable 
imbalance of the noncompacted and compacted myelin compartments which was most 
pronounced in SC of small fibers. Noncompacted myelin is thought to serve as a transport 
network for trophic factors and metabolites. Therefore the reduction of this compartment may 
hamper axonal support, which may have caused the observed loss of predominantly small 
caliber axons in adult CNP deficient mice. Taken together, CNP plays a role in axonal 
support and postdevelopmental negative regulation of myelination and is crucial for the 
integrity of small to mid-sized caliber axons in the PNS. Moreover, myelinating SC display 
individual myelin sheath compositions according to the size of the underlying axon, which 
may resemble precise adjustments to axonal demands. Understanding the myelin biology of 
different fibers may contribute to our understanding of motor and sensory peripheral 
neuropathies.  
1 Introduction 
1.1 The evolution of neuroglia 
An important step in the evolution of complex nervous systems was the differentiation in 
central ganglia plus nerve cord (central nervous system, CNS) and discrete peripheral 
nerves to connect the CNS with peripheral organs (Bullock and Horridge, 1965; Arendt et al., 
2008). Neurons of the CNS and PNS evolved into highly specialized cells for precise and fast 
impulse propagation. Their processes, especially the axons commonly extend over long 
distances, which impedes the supply of distant neuronal domains. Therefore a second major 
step in nervous system evolution was the development of glial cells and their supporting 
association with neurons. As evolution progressed the ratio of glial cells to neurons increased 
(data for frontal cortex in Sherwood et al., 2006) such that pure numbers and complexity of 
neuroglia outnumbered the quantity of neurons by far (Oberheim et al., 2006; Reichenbach, 
1989; Hartline, 2011, 2008). In the mammalian nervous system, we distinguish several 
different CNS and PNS (peripheral nervous system) glial cell types that took over discrete 
but partially overlapping tasks which neurons have abandoned or reduced in evolution. For 
example, the supply of nutrients and trophic factors is carried out by astrocytes and 
oligodendrocytes in the central nervous system as well as by Schwann cells in the peripheral 
nervous system. In addition, the removal of pathogens and dead cells is taken over by 
microglia (CNS) and Schwann cells (SC) and recruited macrophages in the PNS. 
Furthermore, astrocytes (CNS) and terminal SC (PNS) are involved in clearance of 
transmitters and modulation of synaptic transmission. Finally, the insulation of axonal 
segments, together with the ion homeostasis, are the best studied glial tasks which are taken 
over by oligodendrocytes in the CNS and Schwann cells in the PNS. Within the PNS 
mammals have additionally evolved glial cells that also ensheath neuronal cell bodies 
(satellite cells in the ganglia), olfactory ensheathing cells which are limited to the olfactory 
system and enteric ganglia, that are specifically associated with the enteric nervous system 
(summarized in Verkhratsky and Butt, 2013, Glial Physiology and Pathophysiology Chapter 3 
Neuroglia; PNS glia reviewed in Jessen, 2004; Hanani, 2005; Corfas et al., 2004). As the 
work in this thesis is restricted to the analysis of peripheral nerves and their glia, the following 
will primarily focus on glial development and myelination in the PNS. 
  
1.1.1 Evolution of myelin 
The bigger and more complex the organisms became, the greater was the demand for fast 
conduction, rapid reaction, metabolic efficiency, space economy together with stronger 
interconnection and more rapid information processing. Two opposing strategies, which are 
the increase of fiber size or the insulation of fibers, evolved in parallel to enhance conduction 
speed. In vertebrates as well as in some invertebrates insulation was achieved through 
development of multilayered myelin, an elaborated glial membrane that is wrapped around 
the axon and that contains only minimal amounts of electrical conductive cytoplasm in 
between the layers to optimize electrical insulation of enwrapped parts of the axons 
(illustrated in Fig I; reviewed in Hartline and Colman, 2007; Hartline, 2008). In higher 
vertebrates sheaths became compacted, which further raised resistance and elaborated 
compactness within the nervous system. The compaction of these specialized membranes, 
which contain about 70% lipids, especially cholesterol and glycosphingolipids (Norton and 
Autilio, 1965; Fu et al., 1998) is mediated by specific transmembrane (e.g. Myelin Protein 
zero, P0) and membrane associated proteins (e.g. myelin basic protein, MBP). Their 
mutations cause inappropriate myelination and compaction which is frequently associated 
with axonal loss (Giese et al., 1992; Readhead et al., 1987). Hence, the nearly fused 
compact myelin membranes in mammals appear as a layered structure with electron dense 
major dense lines (opposing intracellular sides of membranes) and interperiod lines 
(opposing extracellular membrane sides) (illustrated in Fig I). Additionally, the isolation 
simultaneously reduces the energy demands of neurons as the generation of action 
potentials and therefore ion fluxes are mainly restricted to specialized nodal areas (nodes of 
Ranvier in higher order vertebrates). 
 
Fig I:  Myelin structure in vertebrates and invertebrates 
In vertebrates Schwann cells with a compacted spiraled myelin sheath (A) have evolved. In parallel, invertebrates 
as the Penaeus shrimp (B) developed a compact multilayered sheath with some noncompact areas and a 
submyelinic space. Both structures enormously increase conduction speed. (Adapted from Xu and Terakawa, 
1999)  
1.2 Schwann cells  
1.2.1 The Schwann cell lineage 
In the PNS the isolation of nerve fibers is carried out by Schwann cells (SC). They originate 
from multipotent progenitors of the neural crest (Douarin et al., 1991) in early embryonic 
development. These cells migrate to the developing peripheral nerves and transform to 
Schwann cell precursors (SCP). Reaching their target, SCP, which are in contact with a 
group of axons, develop into immature Schwann cells that engulf the axons and form defined 
axon-Schwann cell bundles. Within the bundles fibers above 1 µm in diameter are sorted out 
and gain a 1 : 1 relationship with a single Schwann cell that transforms into a promyelinating 
SC which will further mature and myelinate the engulfed internode. In contrast, axons smaller 
than 1 µm in diameter remain grouped and engulfed by nonmyelinating Schwann cells to 
form mature Remak bundles (Fraher et al., 1990; Friede and Bischhausen, 1982; Pannese et 
al., 1987; Williams and Wendell-Smith, 1971). The SC development is illustrated in Fig II 
(Jessen and Mirsky, 2005, 2010).  
 
 
Fig II: The Schwann cell lineage 
This drawing shows the Schwann cell lineage progression from migrating neural crest cells to Schwann cell 
precursors (SCP) that are in contact with groups of unsorted axons. SCP develop into immature SC that engulf 
groups of axons and radially sort big axons into 1 : 1 relationships to give rise to myelinating SC. Small axons are 
separated from each other by nonmyelinating SC but remain unmyelinated in Remak bundles. (Adapted from 
Jessen and Mirsky, 2005) 
 
All phases and transitions are accompanied by individual marker expression. Transition from 
SCP to immature SC is irreversible, whereas mature Schwann cells can dedifferentiate to 
immature like repair cells (dashed lines in Fig II) upon peripheral nerve injury.  
1.2.2 Regulation of Schwann cell development 
During early PNS development, it has been shown that growing axons and cells of the 
Schwann cell lineage are interdependent on each other (Morris et al., 1999; Garratt et al., 
2000; Jessen and Mirsky, 2005). Insight came from observations that an ablation of the SC 
lineage specific trophic factor Sox10 or the ErbB3 receptor results in a lack of SCP and SC, 
which secondarily causes the degeneration of originally developed peripheral axons 
(Riethmacher et al., 1997; Britsch et al., 2001; Meyer and Birchmeier, 1995). On the other 
hand, the axonally expressed master regulator Neuregulin1 (Nrg1) inhibits neuronal 
development from neural crest cells (Shah et al., 1994) but promotes survival and 
proliferation of SCP and SC. This interdependence adjusts numbers of SC to axons 
(Birchmeier and Nave, 2008; Newbern and Birchmeier, 2010). From immature stages on, SC 
survival becomes independent of axons. Instead, they establish an autocrine survival loop 
which comprises the expression of growth factors like neurotrophin 3 (NT3), insulin-like 
growth factor 2 (IGF2), platelet-derived growth factor beta (PDGFß) and others (Jessen and 
Mirsky, 2005). This autocrine survival loop is pivotal for SC survival during peripheral nerve 
injury and regeneration. Although their survival is ensured, the fate of Schwann cells after the 
immature SC stage is determined by axonal derived signals such as Nrg1, IGF1 and the 
brain derived neurotrophic factor (BDNF). Those factors trigger radial sorting of large caliber 
axons and promote myelination initiation within the associated SC (Meintanis et al., 2001; 
Cheng et al., 2000; Taveggia et al., 2005). Promyelinating SC upregulate intrinsic feed 
forward signaling cascades involving Krox20, Oct6, Sox10 and NFkB expression but also 
continue to respond to cell-extrinsic trophic factors such as Nrg1, BDNF, IGF1 (Taveggia et 
al., 2005; Jessen and Mirsky, 2008). In early postnatal life promyelinating SC start to extend 
their plasma membrane up to one thousand fold within days so that rapid myelin growth can 
be observed (reviewed in Sherman and Brophy, 2005). As myelination precedes the compact 
myelin sheath is formed.  
 
1.2.3 Regulation of myelin sheath thickness 
Investigations in the early 20th century revealed, that the myelin sheath thickness is 
proportional to the axonal diameter (Donaldson and Hoke, 1905) assuming that it is 
optimized for maximal nerve conduction velocities (Smith and Koles, 1970; Waxman, 1980). 
Furthermore, it was noted that not only the radial but also longitudinal dimension of the 
sheath is proportional to the size of the ensheathed axon defining a specific internodal length 
(Friede and Bischhausen, 1980, 1982). In the peripheral nervous system myelination begins 
at around birth and continues to adulthood (Jessen and Mirsky, 2005). As myelin grows, 
newly formed material is added at the innermost layer of the sheath at the adaxonal side. At 
the same time the sheath also expands longitudinally, thereby defining nodes of Ranvier. 
When development proceeds the cytoplasm between the myelin layers is removed and the 
sheath gets compacted from outside-in (referring to CNS myelination in Snaidero et al., 
2014). Like in SC fate decision, myelin sheath thickness is also at least partially regulated by 
axonal Nrg1. Thus, axonal Nrg1-type III binds to ErbB receptors of the SC surface, which 
further integrate the axonal signals mainly via the MAPK/ERK pathways and/or PI3K/AKT 
pathway to promote lipid synthesis (Pertusa et al., 2007) and myelin protein expression 
(Newbern and Birchmeier, 2010; Michailov et al., 2004; Taveggia et al., 2005; Birchmeier 
and Nave, 2008). Disturbed axonal signaling can substantially impair myelination. For 
example, axonal Nrg1-type III can act bidirectionally as reduced levels result in 
hypomyelination, whereas on the other hand an increase in axonal Nrg1-type III causes a 
severe hypermyelination (Michailov et al., 2004). SC specific defects in the signaling 
pathways can provoke comparable effects. For instance the conditional ablation of ErbB2 
(neuregulin receptor) in immature SC causes a striking hypomyelination (Garratt et al., 
2000). Furthermore, defects in downstream signaling likewise affect myelination. Conditional 
inactivation of extracellular-signaling related kinases 1 and 2 (ERK1/2) in SC dramatically 
reduce myelination (Newbern et al., 2011). Opposing effects can be observed in dominant 
active Mek1DD mutants (constitutive active MAPK signaling) which display a 
hypermyelination by increased myelin protein and lipid synthesis (Ishii et al., 2013; Sheean et 
al., 2014). Interestingly, the inducible reactivation of Raf (upstream activator within the 
MAPK/ERK pathway) in mature myelinated SC induces demyelination and dedifferentiation 
(Napoli et al., 2012). Together these data impose a tight control of myelination with 
upregulation of promyelinating signals in early development and a coordinated 
downregulation as myelination reaches the appropriate myelin sheath thickness. Thus, when 
SC mature, the activity of the promyelinating PI3K/AKT and ERK/MAPK signaling pathways 
as well as the active translational machinery are downregulated to end myelination (Cotter et 
al., 2010; Sheean et al., 2014). Afterwards steady state levels of myelin protein and lipid 
production maintain the myelin sheaths throughout life. 
 
  
1.2.4 Noncompact myelin and the axon-glia interaction 
The compact myelin sheath is optimized for electrical insulation to enable fast impulse 
propagation. Simultaneously it minimizes the access to external factors. Therefore a 
fundamental task of SC is the trophic and metabolic support of shielded axons to preserve 
axonal function and long-term PNS integrity. To this end, SC assemble a complex network of 
cytoplasm filled noncompact myelin regions that comprise Schmidt-Lanterman incisures 
(SLI) which are shortcuts through the compact myelin sheath, the inner tongue which is the 
actual axon-glia interface, the paranodal loops which are the lateral turns of the sheath and 
the inner as well as outer mesaxon, adjacent to first and last layers of the compact myelin 
(dark purple in Fig III). Together they form a network of transport routes, that are further 
connected by “autotypic” gap junctions and adherence junctions (Balice-Gordon et al., 1998; 
Tricaud et al., 2005; brown in Fig III). Presumably, these tracts facilitate the transport of 
myelin components themselves, as the sheath is growing at the inner mesaxon (shown for 
CNS myelin in Snaidero et al., 2014). Moreover, they allow the transport of metabolites for 
the most distal SC regions (innermost myelin layers and inner tongue) and the engulfed axon 
(via the axon-glia interface). Hence, pathological alterations within the noncompact myelin 
compartment may cause demyelination, triggered by insufficient transport of myelin 
components, or axonal degeneration by shortage of metabolites. The arrangement of the 
compartments is illustrated in Fig III.  
 
 
Fig III: Scheme of a myelinated peripheral axon with unrolled sheath 
This scheme displays the organization and interconnections (gap junctions, brown) within the noncompact myelin 
compartment (dark purple) that comprises inner and outer mesaxons, Schmidt-Lanterman incisures (SLI) and 
paranodal loops. Noncompact myelin forms a transport network through the compact myelin sheath (light purple). 
(Adapted from Nave, 2010a) 
To underline the proposed involvement of noncompact myelin defects in the etiology of 
peripheral neuropathies, some glial defects which affect the conjuction and morphology of 
noncompact myelin are highlighted. For example impaired paranodal loop and Schmidt-
Lanterman incisure morphology, as seen when the small integral membrane protein of late 
endosomes (SIMPLE) is mutated, contributes to peripheral nerve degeneration seen in 
CMT1C patients and according mouse models (Lee et al., 2013). Furthermore, 
derangements of noncompact myelin as detectable in MAG (myelin associated glycoprotein) 
mutants may play a fundamental role in pathological processes within peripheral nerves (Yin 
et al., 1998) which is also observable in aged mice and humans. Disruption of the 
innermyelinic transport has also been reported to cause axonal degeneration and 
demyelination as seen by several mutations of the gap junctions protein Connexin 32 (Cx32) 
typically found in men and mice with x-linked Charcot-Marie-Tooth disease (CMTX) (Scherer 
et al., 1995; Hahn et al., 2000, 2001). In addition to hampered innermyelinic transport 
processes, also decreased intercellular transfer along the axon-glia interface impairs nervous 
system integrity. For example, mice with an oligodendrocyte-specific reduction of the 
monocarboxylate transporter 1 (MCT1; likewise reduced in ALS patients) display axonal 
degeneration probably due to chronic undersupply of the engulfed internodal segments (Lee 
et al., 2012). Altogether, it is believed that the balance of compact and noncompact myelin as 
well as the efficient transport within the SC and across the SC-axon junction are necessary 
for long-term axonal survival and PNS integrity.  
Substantial advances in Schwann cell research have been made in the investigation of the 
active involvement of SC in PNS homeostasis through direct axon-glia communication. There 
is increasing evidence that Schwann cells fuel peripheral axons, as oligodendrocytes and 
astrocytes do in the CNS (Pellerin et al., 1998; Fünfschilling et al., 2012; Lee et al., 2012). 
Peripheral nerve ex vivo studies by Vega and coworkers (2003) have shown that SC take up 
glucose which is most likely followed by a supply of lactate to the axon. A severe peripheral 
neuropathy in mice that exhibit non-functional mitochondria in SC (mitochondrial 
transcriptional factor A; Tfam; specifically ablated in SC), further manifested the proposed 
metabolic support to peripheral axons by SC (Viader et al., 2011). Confirmation of a direct 
metabolic coupling in the PNS came from on-demand breakdown of stored glycogen by 
myelinating SC to dynamically provide energy for active peripheral axons (Brown et al., 
2012). Hence, SC not only give rise to the myelin sheath but also support the underlying 
axon. 
  
1.2.5 Additional Schwann cell functions 
Apart from myelination and metabolic support Schwann cells are linked to many other 
processes crucial for peripheral nerve integrity. They are involved in the regulation of axonal 
diameter by an impact on neurofilament phosphorylation (Hsieh et al., 1994; Cole et al., 
1994; Yin et al., 1998). Furthermore they promote ion channel clustering during development 
and maintenance of nodal morphology throughout life. Therefore, axonal and SC membranes 
at the nodal, paranodal and juxtaparanodal regions are interconnected with cell-adhesion 
molecules and adaptor proteins that simultaneously cluster and anchor sodium and 
potassium channels (Poliak and Peles, 2003). Schwann cells are furthermore immune 
competent cells as they are capable to express major histocompatibility complexes (MHCs) 
and other immunomodulatory proteins. Once SC recognize an antigen they start to attract 
immune cells. Additionally they are neuroprotective upon acute injury and can benefit 
peripheral nerve integrity during inflammatory processes (Armati et al., 1990; Armati and 
Pollard, 1996; Ydens et al., 2013). Another myelin independent feature of Schwann cells is 
their formation of a basal lamina and their ability to dedifferentiate and to form Büngner repair 
cells which become crucial in peripheral nerve repair after injury. When SC dedifferentiate, 
promyelinating programs (including myelin protein and lipid production) and positive myelin 
regulators are downregulated, whereas negative regulators of myelination (mostly active 
before myelination) will be reexpressed as seen for instance for c-Jun and Notch (Parkinson 
et al., 2008; Woodhoo et al., 2009). In order to promote axonal regeneration the 
dedifferentiated SC align to form tracts (bands of Büngner) and upregulate specific 
regeneration promoting ECM molecules such as laminins (Wallquist et al., 2002) which 
facilitate directed axonal regrowth. Simultaneously, dedifferentiated SC upregulate the 
expression of neurotrophic factors to promote axonal regrowth as reported for instance for 
Netrin 1 (Madison et al., 2000). In summary, SC take over diverse functions and are 
essential to maintain the PNS integrity in several independent ways. 
 
  
1.2.6 Different myelinating Schwann cell types 
As described above, peripheral nerves are capable of regeneration. In several regeneration 
studies, especially in nerve graft experiments, a preferential regrowth of axons into their 
original tracts has been noted. Motor axons therefore show “preferential motor reinnervation” 
dependent on end organ presence (muscle) and SC characteristics (Höke et al., 2006; 
Madison et al., 2009). Similarly, sensory axons tend to reinnervate sensory tracts more 
efficiently (Höke et al., 2006). On molecular level denervated SC of motor and sensory 
nerves have been found to express “phenotype specific” genes like nerve growth factor 
(NGF), brain-derived growth factor (BDNF), vascular-endothelial growth factor (VEGF), 
insulin-like growth factor (IGF1) and hepatocyte growth factor (HGF) which are upregulated 
in sensory nerves, on the other hand the glial derived neurotrophic factor (GDNF) and 
pleiotrophin (PTN) are increased in motor nerve tracts (Höke et al., 2006; Jesuraj et al., 
2012). These data suggest that SC have a “phenotypic memory” which is only lost during 
expansion in vitro or during prolonged periods of denervation. Moreover, it has been shown 
that recombinant overexpression of NGF indeed increases accuracy of sensory reinnervation 
(Hu et al., 2010). To broaden the spectrum further (Brushart et al., 2013) it has been reported 
that SC of different peripheral nerves in fact express distinct RNA profiles of the above 
mentioned growth factors, implying a variety of distinct myelinating SC types within the PNS. 
Apart from growth factors, cellular adhesion molecules are found in different abundances in 
denervated SC of motor and sensory tracts as shown for L2/HNK1 that is specifically 
expressed in SC formerly associated with motor axons (Martini et al., 1994). Nerve fibers on 
the other hand express specific neuronal cell adhesion molecule (NCAM) and polysialic acid 
(PSA), which interact with the ECM molecules of SC. Regrowing axons fail to show any 
preference for their appropriate tracts if these molecules are ablated (Franz et al., 2005). All 
together, it is evident that motor and sensory SC display differences in peripheral nerve 
regeneration. The phenotypic memory of SC, which is essential for proper reinnervation, on 
the other hand imposes, that SC may as well be different before a nerve injury. However, 
general differences within the population of myelinating SC apart from growth factors and 
adhesion molecules remain largely unknown.  
  
1.3 2’,3’-Cyclic Nucleotide 3’-Phosphodiesterase (CNP) 
Immense contribution to our understanding of myelin functionality has been made by the 
analysis of single myelin proteins. One of those well studied myelin proteins is CNP. In the 
1960s a new enzyme, specifically catalyzing the hydrolysis of 3’-phosphoester bonds in 2’,3’-
cyclic nucleotides, was discovered in the intestinal mucosa. Due to its catalyzed reaction it 
was named 2’,3’-cyclic nucleotide 3’-phosphodiesterase – CNP (Whitfeld et al., 1955). Later 
this protein was found to be enriched in the brain that as well yielded catalytically active CNP 
(Drummond and Perrott-Yee, 1961; Drummond et al., 1962). Refined investigations have 
further restricted CNP to white matter regions of the brain as well as peripheral nerves. Here, 
its activity was specifically linked to the myelin sheath, which was 10 times stronger in the 
CNS compared to PNS samples (Kurihara and Tsukada, 1967). Within myelinating 
oligodendrocytes and SC, CNP was found on the cytoplasmic side of the plasma membrane 
in all noncompact myelin regions (Braun et al., 1988; Trapp et al., 1988). CNP expression 
can be found already in the oligodendrocyte and SC lineage in embryonic stages and is 
therefore one of the earliest markers of myelinating glial cells (Sprinkle et al., 1978a; Scherer 
et al., 1994). 
 
1.3.1 Molecular characteristics of CNP 
The CNP gene is well conserved and shares 96% sequence homology between rat and 
mouse and 86% homology between rat and human (Gravel et al., 1994). Due to two 
alternative promoters, the CNP gene gives rise to two mRNAs and protein isoforms (46 kDa 
and 48 kDa, additional N-terminal mitochondrial localization sequence) (Bernier et al., 1987; 
Kurihara et al., 1990; Lee et al., 2005). Whereas oligodendrocytes and SC generate both 
mRNAs (mainly CNP1) and express both proteins, non-glial cells outside the nervous system 
only express the CNP2-mRNA and the mitochondrial linked CNP2 protein. Interestingly, the 
shorter CNP2-mRNA contains both promoter regions and can therefore give rise to both 
protein isoforms. Within the nervous system, glial precursor cells also mainly express the 
mitochondrial CNP2, whereas in active myelination phases the CNP1 isoform, which is 
localized to noncompact myelin is additionally upregulated (Scherer et al., 1994; O’Neill et 
al., 1997). The transcriptional regulation of CNP1 and CNP2 expression is not yet well 
understood. Insight came from in vitro observations that showed that enhanced cAMP levels 
together with a putative activator can induce especially CNP1 transcription likely resembling 
processes during development and active myelination (Gravel et al., 2000).  
  
1.3.2 Catalytic activity of CNP 
Originally CNP was identified due to its unique site-specific catalytic activity. Ever since, the 
importance of the catalytic function of CNP has been under debate as there was lack of 
evidence for a physiological substrate within the nervous system. However, the catalytic 
domain of CNP was mapped to the C-terminus, which is further reported to be highly 
conserved among vertebrates (Lee et al., 2001). As previously mentioned, the CNP2 isoform 
is associated with mitochondria, except when the mitochondrial localization signal is 
phosphorylated, which prevents its translocation (Lee et al., 2006). Mitochondrial CNP 
seems to be catalytically active and thus influences 2’,3’-cyclic nucleotide levels, which 
trigger the Ca2+-dependent permeability transition pore opening in mitochondria of apoptotic 
cells or in disease (Azarashvili et al., 2009, 2010, 2014). Here, 2’,3’-cAMP and 2’,3’-cNADP 
have been suggested as possible substrates. 2’,3’-cAMP originates from RNA processing 
and could be hydrolyzed to neuroprotective adenosine (Thompson et al., 1994; Ren et al., 
2009; Jackson et al., 2009). Indeed, the CNS has been shown to express the extracellular 
2’,3’-cAMP – adenosine pathway. Therein, CNP efficiently hydrolyses 2’,3’-cAMP to 2’-AMP 
which is further degraded to adenosine. This reaction cycle, which is mainly carried out by 
oligodendrocytes, is highly efficient compared to the production of adenosine from 3’,5’-
cAMP within the brain. This prevents the cytotoxic accumulation of 2’,3’-cAMP and 
simultaneously provides neuroprotective adenosine locally. This pathway is strongly induced 
post injury but additional mutation of CNP worsens the outcome of experimental brain 
injuries (Stone et al., 2009; Verrier et al., 2012, 2013). SC also express adenosine receptors 
(Stevens et al., 2004), we therefore hypothesize that the extracellular 2’,3’-cAMP-adenosine 
pathway may also play a role in the PNS as described above for the CNS.  
 
1.3.3 CNP functions independent of the catalytic activity 
Numerous other observations that may not be related to enzymatic function further propose 
CNP as structural protein essential for cell dynamics and morphology. It has been proposed 
that CNP is a cytoskeleton associated protein. Hence, it preferentially binds to tubulin 
heterodimers and induces microtubule assembly as well as the stabilization of the tubulin 
cytoskeleton. Accordingly, in cultured oligodendrocytes it promotes process outgrowth, which 
was elaborated when CNP was overexpressed (Lee et al., 2005). Importantly, deletion of the 
C-terminal domain (catalytic region) of CNP interferes with the microtubule stability. Along 
with the impact on the tubulin cytoskeleton, CNP has further been shown to bind to 
membranes in an isoprenylation-dependent manner. Therefore it may serve as an adjustable 
linker of cytoskeleton and the adjacent plasma membranes (Braun et al., 1991; Bifulco et al., 
2002). Moreover, CNP is regarded as a linker of RNA granules to the cytoskeleton as CNP 
can furthermore directly bind to RNAs and prevent active translation by interfering with the 
formation of the translation initiation complex. This translational repression may be a 
fundamental role of CNP in coordinated MBP-mRNA-granule transport within glial cells 
(Gravel et al., 2009). Together, these observations in combination with the potential catalytic 
function propose versatile roles for CNP with regard to cellular integrity.  
 
1.3.4 Overexpression and deficiency of CNP 
To further gain insight into the physiological role of CNP within the nervous system, several 
mouse models that harbour CNP mutations have been established. Initially, overexpression 
of human CNP revealed an involvement of CNP in myelination regulation. Thus, a shift 
towards an earlier peak of the myelin gene expression indicated an accelerated maturation of 
oligodendrocytes. Ultrastructurally, these mice exhibit redundant myelin, myelin vacuoles and 
widespread deficits in myelin compaction (lack of MDL). That was at least partially explained 
by defective MBP-mRNA pathfinding or spatial competition (Gravel et al., 1996; Yin et al., 
1997). Thereafter, CNP deficient mice have been engineered by replacing the CNP open 
reading frame by the Cre-recombinase sequence. Homozygous mice are viable and 
inconspicuous in development and juvenile stages but start to develop a phenotype at four 
months, which deteriorates with age leading to premature death at around 9-11 months. 
Examining their central nervous system a striking neurodegeneration with pronounced white 
matter atrophy and astrogliosis as well as microgliosis can be observed. Interestingly, the 
CNS myelin ultrastructure was reported to be normal (Lappe-Siefke et al., 2003). Later, 
refined investigations of their spinal cords and optic nerves uncovered degeneration of small 
caliber fibers as early as postnatal day 5. Additionally abnormally enlarged inner tongues as 
well as the accumulation of myelin spheroids have been observed throughout life (Edgar et 
al., 2009). Moreover, a progressive disorganization of nodal structures in CNP deficient optic 
nerves occurs even before the onset of axonal degeneration (Rasband et al., 2005). 
Together, the pathological alterations indicate a role of CNP in regulation and maintenance 
of noncompact myelin structures that furthermore have an impact on the compact myelin 
sheath. Recently published ultrastructural observations of fastened compaction within the 
developing CNS of CNP deficient mice (Snaidero et al., 2014) confirmed the importance of 
CNP as myelin regulator and structural coordinator. So far, the role of CNP in SC and its 
importance for PNS integrity had not been analyzed.  
  
1.3.5 CNP in disease 
Peripheral neuropathies are commonly accompanied by demyelination and thus reduced 
myelin protein expression. Decreased CNP levels have early been reported for mouse 
mutants with a defective myelin sheath for instance tremblerJ (PMP22 point mutation; Lewis 
et al., 1984) and twitcher mice (GalC deficiency; Mikoshiba et al., 1985). It remained elusive 
if reduced CNP levels are directly involved in disease etiology. Furthermore, a potential 
involvement of CNP function in nervous system degeneration and regeneration has been 
suggested by LeBlanc and coworkers (1992) who observed decreased CNPase activity 
during degeneration phases in experimental peripheral neuropathies followed by an increase 
in activity during regeneration. CNP was also connected to several human diseases for 
instance schizophrenia (Peirce et al., 2006) as the CNP gene lies within a chromosomal 
region that is linked to the disease. Moreover, the brains of schizophrenic patients frequently 
show reduced CNP levels. This can be nicely resembled by aged CNP heterozygous mice, 
that also show a catatonia-depression syndrome, a schizophrenia-associated disorder 
(Hagemeyer et al., 2012). Additionally, decreased levels of CNP have further been observed 
in patients with Down syndrome or Alzheimer’s disease (Vlkolinský et al., 2001). Moreover, 
multiple sclerosis patients frequently show elevated CNP levels in their cerebrospinal fluid 
(Sprinkle et al., 1978b; Suda et al., 1984). More recently, CNP has been shown to have T-
cell-attractive properties and may therefore directly influence development of multiple 
sclerosis (Muraro et al., 2002). Together, these data suggest a role of CNP in a variety of 
diseases possibly referring to a final common pathway in degeneration of central white 
matter. Surprisingly, the connection to human disease has only been shown for reduced 
CNP levels but no loss- or gain-of-function mutations have been reported to date. However, 




1.4 Aim of the study 
Motor and sensory SC of injured peripheral nerves differ with regard to the expression of 
regeneration promoting factors to specifically promote the regrowth of appropriate axons. 
The “phenotypic memory” implies that differences between the two SC types are established 
in development and can be observed also in uninjured nerves. We hypothesized, that 
specific characteristics of motor and sensory SC not only comprise extracellular matrix 
components and trophic factors but potentially involve basic differences in the myelin 
constitution, as SC are associated with distinct axonal subtypes that likewise display different 
features. In this work the postulated myelin sheath diversity was addressed by comparative 
proteome analyses and quantitative proteinbiochemical investigations of purified myelin from 
motor and sensory nerves. Finding variability in their myelin composition, the question about 
the differential importance of single myelin proteins for discrete fiber types arose. Having 
found, that the noncompact myelin protein CNP is indeed differentially expressed, the 
second and major part of this work addressed the role of CNP function within the PNS. Initial 
investigations focused on the question of whether CNP, which is ten times less abundant in 
the PNS compared to the CNS, has a similar impact on SC functionality and peripheral nerve 
integrity as it was shown for oligodendrocytes in the CNS. To this end, peripheral nerves of 
CNP deficient mice were compared to nerves of wildtype animals. Histological and electron 
microscopic analyses aimed to uncover morphological alterations particularly in SC but also 
on the axonal side. Special emphasis was placed on the differentiation of changes within the 
noncompact and compact myelin compartment. Furthermore, analyses of gene regulation 
and activity of signaling pathways provided insight in underlying pathomechanisms. In 
relation to the differential protein expression between SC types, CNP is a good candidate to 
investigate the particular importance of myelin proteins for discrete fiber populations. 
Therefore, refined morphological and biochemical analyses of different peripheral nerves 
emphasized the specific impact of CNP function on large and small fiber integrity in the PNS. 
This work aimed to combine the analysis of a general SC diversity with respect to their 
myelin sheaths, and the detailed investigation of one differentially expressed protein (CNP) 
with special emphasis to its particular importance for the integrity of discrete peripheral nerve 
fiber subpopulations.  
  
2 Materials 
2.1 Chemicals and consumables 
Except otherwise stated all chemicals and consumables are purchased from Sigma-Aldrich, 




Ketamine, 10% CP-Pharma 
Low fat milk powder Frema 
Rompun, 2% Bayer 
 
Electron microscopy 
Azur II Merck 
Eukit Kindler / Science Services 
Formvar Plano 
Glutardialdehyde Electron Microscopy Science (EMS) 
Glycid ether 100 Serva 
Lead citrate Merck 
Methylnadic anhydride Serva 
Methylene blue Merck 
Osmium tetraoxide Science Services 
Propylene oxide Serva 
Polyvinylpyrrolidone (PVP filler) Sigma-Aldrich 
2,4,6-Tris(dimethylaminomethyl)phenol Science Services 




Ammonium persulfate (APS) BioRad 
Bromphenol blue Sigma 
Complete Mini (Protease inhibitors) Roche 
Formaldehyde 37% Merck 
Glycine Sigma 
2-Mercaptoethanol Fluka 
PhosStop (Phosphatase inhibitors) Roche 
Prestained Page Ruler Plus Fermentas 
SDS (Dodecylsulfate sodium salt) Serva 
TEMED Serva 
Trizma Base Sigma 





GenRuler 1 kb DNA ladder  Fermentas 
GenRuler 100 bp DNA ladder  Fermentas 
GoTaq polymerase Promega 
Power SybrGreen Applied Biosystems 
Trizol Reagent Invitrogen 
Superscript III-reverse Transcriptase Invitrogen 
 
Immunohistochemisty 
Aqua Polymount Polysciences 
Goat serum Gibco 
Haematoxylin (hemalum solution) Merck 
Horse serum Gibco 
Paraformaldehyde, pure Serva 
 
Consumables 
Copper grids (100Mesh, Guitarr, Slot) Gilder Grids 
Coverslips Thermo Scientific Menzel-Gläser 
Histobond slides Marienfeld 
PVDF Western Blotting membranes Roche 
Superfrost Plus slides Thermo Scientific Menzel-Gläser 
 
Kits 
Agilent RNA 6000 Nano Kit Agilent 
DAB Substrate Kit Zytomed 
DC Protein Assay Kit BioRad 
Genomic DNA-Isolation Kit Nexttec 
GoTaq DNA polymerase Promega 
RNeasy Mini / Micro Kit Qiagen  
SuperScript III Reverse Transcriptase Invitrogen 
Vectastain Elite ABC Kit Vector 
Western Lightning Plus ECL Perkin Elmer Life Sciences 
 
Machines 
AFS II Leica 
Agilent 2100 Bioanalyzer Agilent 
Axiophot Observer inverted Zeiss 
Centrifuge 5415R Eppendorf 
Diamond knife Histo (45º/Ultra 45°) Diatome 
Embedding center AP280-1/2/3 Microm 




Intas ChemoStar Intas 
Light Cycler 480 Roche 
NanoDrop200 Spectraphotometer Thermo Scientific 
Optima TLX Ultracentrifuge Beckman  
Precellyse24 Bertin Technologies 
PCR-machine PeqLab 
Sled microtome Microm 
Thermomax microplate reader MGW Biotech 
Tissue Processor HMP110 Microm 
Ultracut Leica 
UV illuminator Intas 
Wet Chamber Blotting System BioRad 




2.2 Solutions and buffers 
Avertin 
2% [w/v] 2,2,2-Tribrome ethanol 99% 
2% [v/v] Amyl alcohol 
Mix at 40°C for 30 min while stirring. To be filtered before storage at -20°C. 
 
Anesthetic 
4 mg Xylazine (2% Rompun, BayerVital)  
60 mg Ketamine (10% Ketamin, WDT) 
Intraperitoneal injection of 6 mg Ketamine and 90 mg Xylazine per kg of bodyweight per 
mouse. 
 
1x Phosphate buffered saline (PBS) 
170 mM  Sodium chloride 
3,4 mM Potassium chloride 
4 mM di-Sodium hydrogen phosphate 
1,8 mM  di-Potassium hydrogene phosphate 
Adjust to pH 7.4 with 1 N NaOH. 
 
0.1 M Phosphate buffer (working solution) 
0,2 M NaH2PO4 (Stock solution) 
0,2 M Na2HPO4 (Stock solution) 
Mix in 1 : 5 ratio and add equal amount of ddH2O. 
 
Fixatives 
16% Paraformaldehyde (PFA stock solution) 
16% [w/v] Paraformaldehyde 
Stir for 20 min at 60°C and subsequently increase pH with NaOH to allow full dissolution. 
Store at -20°C. 
 
4% PFA in PBS (Fixative) 
4% [v/v] Paraformaldehyde 
0,1 M  Phosphate buffer 
0,8% [w/v] Sodium chloride 
Adjust pH to 7.4 before use. 
  
K&S fixative (according to Schultz and Karlsson, 1965) 
25% [v/v] 16% Paraformaldehyde 
2,5% [v/v] Glutardialdehyde 
50% [v/v] 0.2 M phosphate buffer 
0,08 M Sodium chloride 
Adjust pH to 7.4 before use. 
 
Molecular biology 
dNTPs (50x stock solution) 
25 mM of dATP, dGTP, dCTP, dTTP (Boehringer, Mannheim) 
 
TBE 20x (stock solution) 
1.8 M TrisBase 
1.8 M Boric acid 
200 mM EDTA 
 
Protein biochemical solutions 
Sucrose buffer (Homogenisation) 
320 mM  Sucrose 
10 mM Tris-HCl pH 7.4 
1 mM Sodium hydrogen carbonate 
1 mM Magnesium chloride 
Add proteinase inhibitors and optionally phosphatase inhibitors before use. 
 
Running buffer (Laemmli buffer working solution) 
25 mM TrisBase 
192 mM Glycine 
1% [w/v] SDS 
 
Transfer buffer (1x for wet chamber blotting) 
48 mM TrisBase 
39 mM Glycine 
20% [v/v] Methanol 
 
  
Tris buffered saline with Tween20 (TBST) 
50 mM Tris-HCl (pH 7.4) 
150 mM Sodium chloride 
0.05% [v/v] Tween20 
 
Protein loading dye (4x) 
40% [w/v] Glycine 
240 mM Tris-HCl pH 6.8 
8% [w/v] SDS 
0,04% [w/v] Bromphenole blue 
 
SDS separation gel 
10-16% [v/v] Acrylamide / Bisacrylamide 29 : 1 
0,4 M Tris-HCl pH 8.8 
0,1% [w/v] SDS 
0,03% [v/v] Ammonium persulfate 
0,08% [v/v] TEMED 
 
SDS stacking gel 
4% [v/v] Acrylamide / Bisacrylamide 29 : 1 
125 mM Tris-HCl pH 6.8 
0,1% [w/v] SDS 
0,05% [w/v] Ammonium persulfate 
0,1% [w/v] TEMED 
 
Sucrose solution for myelin purification 
0.29 M Sucrose 
0.85 M Sucrose 
Add protease inhibitors to the solutions. 
 
Gel fixative (for silver and coomassie stainings) 
40% [v/v] Ethanol 
10% [v/v] Acetic acid 
 
  
Solutions for electron microscopy 
Reynolds lead citrate solutions (Reynolds, 1963) 
1.33 g Lead nitrate 
1.76 g Sodium citrate 
Solve in 30 ml ddH2O while shaking. After 30 min add 8 ml of 1 M NaOH to adjust the pH to 
12. Add ddH2O to 50 ml. Sterile filter before use.  
 
Uranyl acetate 
4% [w/v] Uranyl acetate 
Aqueous solution has to be filtered before use. 
 
Epoxy resin (Epon) 
21.4 g Glycid ether 100 
14.4 g DDSA (Serva, 20755) 
11.3 g MNA (Serva, 29452) 
Stir for 10 min and subsequently add 0.84 ml DMP-30. Stir for another 20 min. 
 
Formvar solution 
1.25% [w/v] Formvar 
50 ml Chloroform 
Stir for at least 30 min. Protect from light. Store at room temperature. 
 
Richardson’s Methylene blue / Azure II blue (Richardson et al., 1960) 
1% [w/v] Azure II in ddH2O (Stock solution 1) 
1% [w/v] Methylene Blue in 1% Borax (Sodium borate) (Stock solution 2) 
Mix equal amount of stock solutions and filter before use. 
 
Histological staining solutions 
Citrate buffer (0.01 M, pH 6.0) 
1.8 mM Citric acid 
8.2 mM Sodium citrate 
Always prepare freshly and adjust pH to 6.0. 
 
Tris buffer (50 mM, pH 7.6) 
50 mM Tris-HCl pH 7.6 
0.9% [w/v] Sodium chloride 
Prepare freshly and adjust pH to 7.6. 
Tris buffered milk 
50 mM Tris-HCl pH 7.6 
0.9% [w/v] Sodium chloride 
2% [w/v] Low fat milk powder 
Stir for 20 min at room temperature and filter before use. 
 
Blocking solution (PBS / BSA) 
40 mM Sodium dihydrogen phosphate 
160 mM Disodium hydrogen phosphate 
1.8% [w/v] Sodium chloride 
1.0% [w/v] Bovine serum albumin  
1.0% [w/v] Goat serum 
 
Blocking buffer for teased fiber stainings 
10% [v/v] Horse serum 
0.1% [v/v] Tween20 
Add freshly to phosphate buffered saline (1x PBS). 
 
Mayer’s haematoxylin solution (nuclear stain)  
0.1% [w/v] Hematoxylin 
0.02% [w/v] Sodium iodate 
5% [w/v] Potassium aluminium sulfate  
Add following substances while shaking. 
5% [w/v] Chloral hydrate 
0.1% [w/v] Citric acid 
Solution turns violet blue. Has to be filtered before use. 
 
HCl-Alcohol 
0.09% [v/v] Hydrogen chloride fuming 
70% [v/v] Ethanol 
 
Scott’s solution 
0.2% [w/v] Potassium hydrogen carbonate 





Actin  Sigma #A3853 mouse 1 : 5000  
AKT  Cell signaling #4691 rabbit 1 : 1000 
p-AKT Cell signaling #3787 rabbit 1 : 1000 
Caspr  Neuromab (#P97846) mouse 1 : 750 (WB) / 1 : 200 (IHC) 
CD3 Serotec (#MCA1477) rat 1 : 150 (IHC) 
CNPase  Sigma #C5922 mouse  1 : 5000 (WB) / 1 : 150 (IHC) 
Cx29  Life Tech #34-4200 rabbit 1 : 500 
DAPI Roche (#10236276001) all DNA 1 : 20000 (IHC) 
DM20/PLP (A431) selfmade Dept. Nave rabbit 1 : 5000 (WB) 
GAPDH Stressgene #CSA-335 mouse 1 : 5000 
MAC3 BP-Pharmingen (#553322) rat 1 : 400 (IHC) 
MAG  Chemicon #MAB1567 mouse 1 : 500 (WB) / 1 : 50 (IHC) 
MAPK  Cell signaling #4695 rabbit 1 : 1000 
p-MAPK  Cell signaling #9101 rabbit 1 : 1000 
MBP  Dako #A0623 rabbit 1 : 5000 (WB) / 1 : 500 (IHC) 
MBP Serotec (#MCA409S) rat 1 : 400 (IHC) 
MyP2  Santa Cruz #49304 goat 1 : 200 (WB) 
Nav1.6  Alomone Labs (#ASC009) rabbit 1 : 500 (IHC) 
Peripherin Millipore (#AB1530) rabbit 1 : 400 (IHC) 
Sept2  PTG #11397 rabbit 1 : 500 
Sirt2  Southwood et al., 2006) rabbit 1 : 2000 
Tuj1 (tubulin beta III) Covance (#PRB-435P) rabbit 1 : 400 (IHC) 
 
Secondary antibodies 
Mouse-HRP Dianova (#115-035-003) goat 1 : 5000 (WB) 
Rabbit-HRP Dianova (#111-035-003) goat 1 : 5000 (WB) 
Goat-HRP Dianova (#705-035-003) donkey 1 : 5000 (WB) 
Mouse-A488 Invitrogen (#A21202) donkey 1 : 2000 (IHC) 
Mouse-A555 Invitrogen (#A31570) donkey 1 : 2000 (IHC) 
Rabbit-A488 Dianova (#711-545-152) donkey 1 : 2000 (IHC) 
Rabbit-A555 Dianova (#111-545-144) donkey 1 : 2000 (IHC) 
Rat-Dyeligh633 YoProteins (#309) donkey 1 : 500 (IHC) 
Rat-Biotin Vector (#BA-9400) rabbit 1 : 1000 (IHC)  
2.4 Primers 
All oligonucleotides were synthesized by the AGCT-laboratory of the Max Planck Institute for 
Experimental Medicine. 
 
CNCE genotyping primer 
CNP fwd:  GCCTTCAAACTGTCCATCTC (Exon3 upstream of Bgl-II side) (#2016) 
CNP rev:  CCCAGCCCTTTTATTACCAC (Exon3 downstream of Bgl-II side) (#7315) 
Cre fwd: CCTGGAAAATGCTTCTGTCCG (sense in Cre sequence) (#4193) 
Cre rev: CAGGGTGTTATAAGCAATCCC (antisense in Cre sequence) (#4192) 
 
qRT-PCR primer 
bACT fwd: CGCTCAGGAGGAGCAATG  rev: TGACAGGATGCAGAAGGAGA 
CNP fwd: CGCTGGGGCAGAAGAATA  rev: AAGGCCTTGCCATACGATCT 
CycPh fwd: CACAAACGGTTCCCAGTTTT  rev: TTCCCAAAGACCACATGCTT 
HmgCR fwd: CAACCTTCTACCTCAGCAAGC  rev: CACAGTGCCACATACAATTCG 
MAG fwd: TCTACCCGGGATTGTCACTG  rev: GCAGCCTCCTCTCAGATCC 
MBP fwd: GCCTGTCCCTCAGCAGATT  rev: GCCTCCGTAGCCAAATCC 
P0 fwd: TGCCCTGCTCTTCTCTTCTT rev: CCTGTCCGTGTAAACCACAA 
PLP fwd: TCAGTCTATTGCCTTCCCTAGC rev: AGCATTCCATGGGAGAACAC 
RPLP0 fwd: GATGCCCAGGGAAGACAG  rev: ACAATGAAGCATTTTGGATAATCA 
RSP13 fwd: CGAAAGCACCTTGAGAGGAA  rev: TTCCAATTAGGTGGGAGCAC 
SCAP fwd: CTCAGGGGCAATCACAGC  rev: TGAGCAAATGTTTGGCTGAC 
dT TTTTTTTTTTTTTTTTTTTTTTTVN anchored oligo-dT mix for cDNA synthesis 
N9 NNNNNNNNN random nonamers for cDNA synthesis 
  
3 Methods 
3.1 Animals and behaviour 
All investigations were performed in accordance with the German animal welfare law and the 
Lower Saxony State regulation for animal experiments. Animals were bred and kept in the 
animal facility of the Max Planck Institute of Experimental Medicine. Animals were kept in a 
12h-light-dark-cycle and all handling and investigations were carried out in the light phase. 
For this work C57Bl6 animals were used as wildtype controls and homozygous CNP-Cre 
mice (MGI nomenclature Cnptm1(cre)Kan; Lappe-Siefke et al., 2003) as CNP deficient mutants. 
Animals were obtained from heterozygous breedings. Whenever possible, littermates of the 
same gender were housed in groups to reduce stress due to social isolation.  
 
Genotyping 
Tail biopsies were digested and gDNA harvested following manufacturer’s instructions using 
the Genomic DNA-Isolation Kit for Tissue and Cells (NextTec). Eluted DNA was diluted 1 : 5 
to exclude overload of the PCR and occurrence of unspecific bands. 0.5 µl diluted DNA was 
used for genotyping. 
 
CNP-PCR      Program: 
0.3 µl Primer 4192 (10 pM) 95°C 180 s  melting 
0.3 µl Primer 4193 (10 pM) 56°C 30 s  annealing 
1 µl Primer 2016 (10 pM) 72°C 60 s  elongation 
1 µl Primer 7315 (10 pM)  95°C 30 s melting 
4 µl 5x GoTaq Buffer back to step 2  37 cycles 
2 µl dNTPs (10 mM) 56°C 60 s final annealing 
0.1 µl GoTaq 72°C 600 s final elongation 
11.3 µl ddH2O  
 
 
For visualization GelRed was added in a 1 : 20000 ratio to each PCR reaction. PCR products 
were separated with 1.5% agarose gels in TBE buffer. The wildtype allele was presented by 




All sensory and motor behavioural tests were carried out blinded and with standardized 
methods. For sensory assessments animals were placed in the testing cages on the grid or 
plexiglass base of the dynamic plantar aesthesiometer (Ugo Basile, Borghi, Italy) and 
habituated to the setup for two hours. For mechanical sensitivity testing the plantar surface of 
the hindpaw was stimulated with a 0.5 mm Von-Frey-type filament. During testing phase the 
mechanical force increased by 1 g / s and the stimulus intensity that induced paw withdrawal 
was recorded. If the paw was not lifted within 20 s the test was stopped to prevent tissue 
damage. Each animal was tested 5 times per hindpaw and the mean of all recordings per 
mouse was calculated. In order to assess the thermal sensitivity the plantar surface was 
irradiated with an infrared beam (40% beam power). Paw withdrawal latencies were 
calculated from 5 independent trials per hindpaw per animal.  
Additionally motor abilities of CNP and control animals were investigated. Therefore, the 
animal was placed on an 8 mm round bar with rough surface and the holding time (maximum 
3 min) was measured (Bar test). Results were displayed as sum of the 5 trials. Furthermore, 
in the grip strength test the animal had to grab a horizontal T-bar which was connected to a 
gauge. As the animal was pulled away the maximum force before the animal lost the grip 
was traced. The mean grip strength was calculated from five independent tests per mouse. 
Motor coordination was further investigated as the mouse had to pass a 2 m grid (1 cm grid 
size) and all complete slips through the grid were counted (Grid slip test).  
 
Electrophysiological assessment 
Animals were anesthetized with Xylazine / Ketamine to have a time window of 20 min to 
perform all recordings under deep anesthesia. One pair of needle electrodes (Schuler 
Medizintechnik) was placed close to the sciatic notch (proximal) and one pair next to the 
tibial nerve in vicinity to the ankle (distal). Motor recording electrodes were positioned in the 
small foot muscle of the plantar surface. Compound muscle action potentials (CMAPs) were 
recorded after proximal and distal supramaximal stimulation of the sciatic and respective 
tibial nerve. The difference of responses, together with the distance of the stimulation 
electrodes allowed the calculation of the motor nerve conduction velocity (mNCV). For 
sensory recordings distal electrodes next to the tibial nerve were used for stimulation and the 
electrodes in proximity to the sciatic notch served as recording electrodes. The sensory 
nerve fibers were stimulated 10 times consecutively and the mean trace (sensory nerve 
potential) was calculated automatically. In combination with the distance of the electrodes the 
sensory nerve conduction velocity (sNCV) was calculated from the latency of the response.  
3.2 Tissue preparation 
Peripheral nerve preparation 
Animals were sacrificed by cervical dislocation. Subsequently sciatic and saphenous nerves, 
as well as dorsal and ventral roots were carefully dissected. For immunohistological 
assessments nerves were immersion fixed for 24 h at 4°C in 4% PFA. Nerves for electron 
microscopic investigations were transferred to K&S-fixative (4% PFA and 2.5% 
glutardialdehyde, according to Schultz and Karlsson, 1965) which allows better structural 
preservation. To allow refined ultrastructural analyses saphenous nerves were cryofixed 
under high pressure (HPF). Therefore freshly dissected nerves were cut into suitable pieces 
and mounted in 0.2 mm carriers using 20% polyvinylpyrrolidone in PBS (PVP) as filler. 
Subsequently the samples were frozen under high pressure thus preventing tissue damage 
by ice crystal formation. HPF samples were stored in liquid nitrogen before freeze 
substitution. For RNA profiling or protein analyses the tissue was either snap frozen and 
stored at -80°C or was immediately processed after dissection.  
 
Teased fiber preparation 
Sciatic nerves of adult mice were freshly cut and transferred into cold PBS. Using fine 
forceps the endoneuria were carefully removed and nerves were split longitudinally into 
smaller proportions. Small nerve samples were transferred to a droplet of cold PBS on a 
superfrost slide. Thereafter, fibers were carefully separated to achieve areas where axons 
are completely separated from each other. Reaching a good separation of fibers the samples 
were dried. Teased fibers were stored at -20°C if not processed immediately.  
 
3.3 Electron microscopy 
K&S-fixed nerves were postfixed in 2% osmium tetraoxide and subsequently dehydrated and 
embedded in epoxy resin (protocol page 35). High pressure frozen material was processed 
using 0.1% tannic acid as mordant and 2% osmium tetraoxide for postfixation. Subsequent 
steps of the freeze substitution (protocol page 35) from warm up and dehydration over epon 
infiltration to final polymerization were performed automated using the AFS II (Leica). Epon 
embedded nerves were cut in longitudinal or transverse direction as 0.5 µm semithin or 
50 nm ultrathin sections (Ultracut S ultramicrotome, Leica). Semithin sections were stained 
with methylene blue / Azure II blue (according to Richardson, 1960) for 1 min to visualize 
lipid rich tissue (myelin). Ultrathin sections were contrasted with 4% uranyl acetate for 30 min 
and lead citrate for 7 min (according to Reynolds, 1963). The contrasting of ultrathin sections 
of HPF samples was adapted to 15 min uranyl acetate and 3 min lead citrate incubation. 
Electron micrographs were taken with the EM900 (Zeiss; 3.500x – 30.000x magnification) or 
EM912AB (Zeiss; high magnification) electron microscopes which are equipped with wide-
angle dual speed 2K-CCD-Cameras (TRS, Moorenweis) using the ImageSP software (TRS, 
SysProg, ImageSP vers. 1.1.4.62). Image analysis was carried out with ImageJ vers1.42q.  
 
3.4 Histology 
After peripheral nerves had been immersion fixed for 24 h in 4% PFA they were washed with 
PBS and embedded in 2% low melting agarose (BactoAgar, BD) to allow for easy 
arrangement of nerves. The tissue was dehydrated, paraffin wax infiltrated (protocol page 
36) and positioned in wax blocks. 5 µm sections were assembled and mounted on slides and 
dried over night at 37°C. For stainings sections were rehydrated (protocol page 36).  
 
DAB 
Within the rehydrated sections the endogenous peroxidase was inactivated by incubation 
with 3% hydrogen peroxide for 5 min followed by several washing steps with Tris buffered 
milk. To reduce unspecific staining, sections were incubated for 20 min in blocking solution 
(containing inactivated goat serum and bovine serum albumin) followed by overnight 
incubation with the primary antibody (for dilution see page 24) in Antibody-Diluent (DAKO) at 
4°C. Subsequently, sections were washed with Tris buffered milk and incubated for 30 min at 
RT with the specific biotinylated secondary antibody in Antibody-Diluent (DAKO). After 
washing the sections with Tris buffered milk the streptavidin-coupled HRP-conjugated 
bridging antibody was applied following manufacturers instructions (Vectastain Elite ABC kit; 
Vector). Repeated washing steps with Tris-buffer were followed by the enzyme based 
detection of the antigen with the help of the diaminobenzidine (DAB) precipitation reaction 
(DAB Substrate Kit, Zytomed). Afterwards, the sections were counterstained with 
hematoxylin and dehydrated (protocol page 36) before mounting. 
 
Fluorescent labeling 
For immunofluorescence labeling rehydrated sections were blocked for 20 min with goat 
serum and bovine serum albumin followed by overnight incubation (at 4°C) with primary 
antibodies in blocking solution (for dilutions see page 24). Following subsequent washing 
steps with Tris buffered milk, sections were incubated for 60 min with the corresponding 
fluorescently labeled secondary antibodies. DAPI was commonly added to the secondary 
antibody dilutions to gian a nuclear counterstain. Finally, sections were washed and mounted 
with Aquapolymount. 
 
Teased fiber staining 
Teased fibers were postfixed on slide for 5 min in freshly prepared 4% PFA and 
permeabilized with icecold methanol for additional 5 min. After three subsequent washes with 
phosphate buffered saline (PBS) for 5 minutes, the fibers were blocked for 2 h with 10% 
horse serum and 0.1% Tween20 in PBS at room temperature. Hereafter, the tissue was 
incubated over night at 4°C with the primary antibodies (dilutions see page 24). The slides 
were washed three times with PBS. Appropriate secondary antibodies (page 24) were 
applied to the fibers for 1 hour at room temperature. After final washing with PBS fibers were 
mounted with Aquapolymount.  
 
Light microscopy 
Light microscopic images of semithin sections or DAB stainings were taken with the Zeiss 
Image Z1 microscope. For overview images the 20x (Plan-Neofluar 20x 0.50 Air; Zeiss) and 
for tile images the 100x (Plan-Neofluar 100x 1.30 Oil, Zeiss) objectives were used. Images 
were taken with the help of the ZEN2011 (Zeiss) software. Fluorescent images were 
captured with the Axiophot Observer Z (inverted, Zeiss). Overview images were taken with 
the 20x objective, whereas high magnification images were taken using the 63x (C-
Apochromat, Zeiss) objective. For image acquisition ZEN2012 (Zeiss) software and for 
image analysis ImageJ vers1.42q software was used.  
 
3.5 RNA isolation and analysis 
RNA extraction 
Snap frozen or freshly prepared dorsal and ventral roots were homogenized in Trizol 
(Invitrogen) by shaking twice for 10 s at 5500 rpm using the Precellyse24 (Bertin 
Technologies). Total RNA was extracted following manufacturer’s instructions for “RNA 
extraction from lipid rich tissue” with the help of RNeasy Mini- or MicroRNA Kits (Qiagen). 
RNA concentrations and qualities were analyzed with Agilent RNA 6000 Nano Kits (Agilent) 





For quantitative mRNA comparisons equal amounts of total RNA (per experiment 200 ng-
1 µg) were reversely transcribed to cDNA providing excess of random nonamers (N9) and 
oligodesoxythymidine primers (dT) as well as dNTPs using the SuperScript III reverse 
transcriptase (Invitrogen). 
First strand cDNA synthesis 
8 µl RNA (~500 ng) 
2 µl Oligo dT mix primer (0.6 µM) 
2 µl N9 random nonamer primer (0.12 mM) 
Incubated for 2 min at 70°C to denature all double stranded RNAs and primers. Briefly put on 
ice before proceeding. 
4 µl 5x 1st strand buffer 
2 µl 100 mM DTT 
2 µl 10 mM dNTPs  
1 µl SuperScript III reverse transcriptase (200 U / µl) 
Mastermix 2 was added to each reaction. The final 20 µl reaction was incubated for 10 min at 
25°C followed by 45 min incubation at 50°C and final incubation at 55°C for another 45 min. 
Synthesized cDNAs were diluted to 1 ng / µl.  
 
Quantitative real time polymerase chain reaction (qRT-PCR) 
Quantitative real time PCRs were carried out using the SybrGreen system (Applied 
Biosystems) and 1-2 ng of cDNA per reaction.  
Pipette scheme per reaction (4 technical replicates were used) 
2 µl cDNA 
5 µl Power SybrGreen master mix 
0.2 µl forward primer (100 µM) 
0.2 µl reverse primer (100 µM) 
2.6 µl ddH2O 
Program: 
50°C 120 s warm up 
95°C 600 s melting 
60°C 20 s annealing 
72°C 30 s elongation and detection 
95°C 10 s melting  back to step 3  45 cycles 
Raw data were collected with the Light cycler 480 (Roche, 384 well plates) or the 7500 Fast 
real-time PCR system (Applied Biosystems, 96 well plated), both equipped with according 
softwares (LightCycler®480 software 1.5.0SP4 / 7500FastSystem SDS software). Relative 
quantities (RU) were calculated from the four technical replicates using the internal software. 
Data analysis was carried out using Microsoft Excel 2007. To standardize for differences in 
the cDNA input, all tested genes were normalized to the following standard genes: ribosomal 
protein large P0 (RPLP0), ribosomal protein S13 (RSP13), Cyclophilin (CycPh) and 
betaActin (bAct). The average of all biological replicates was calculated and all values were 
related to wildtype dorsal root levels that were set to 1. 
 
3.6 Proteinbiochemical analysis 
Protein extraction 
Freshly dissected or snap frozen material was homogenized in sucrose buffer, which 
additionally contained protease inhibitors as well as phosphatase inhibitors if neccessary. 
Protein concentrations of the homogenates were measured using the BioRad DCTM Protein 
Assay system (BioRad) according to producer’s protocol. First, bovine serum albumin in 
concentrations from 0.2 – 3 µg / µl was measured to calculate a standard curve. All samples 
were quantified relative to the standards. To ensure loading of equal amounts samples were 
adjusted to the same concentration.  
 
Myelin protein purification 
Most protein biochemical analyses were carried out on purified myelin. Therefore preferably 
freshly dissected peripheral nerve tissue was homogenizes (Precellyse24: 2x 10s at 
5500 rpm) in 1 ml of 0.29 M sucrose containing protease inhibitors. Centrifugation tubes 
were prepared with 1 ml of 0.85 M sucrose solution. The 1 ml homogenates were carefully 
layered over the 0.85 M sucrose without mixing the solutions. After centrifugation at 
35000 rpm (using the TLS55 rotor, ~75000 g) for 30 min, the interphases were transferred to 
new centrifugation tubes and clean water was added in excess to wash out the sucrose. 
These solutions were centrifuged for another 20 min at 35000 rpm (TLS55 rotor, ~75.000 g) 
to receive a protein pellet. Supernatants were carefully removed. Pellets were resuspended 
in clean water and incubated for 15 min on ice to solve cytoplamic proteins. After final low 
speed centrifugation at 16000 rpm for 15 min (TLS55 rotor, ~12000 g) the supernatants were 
removed carefully and myelin protein pellets were resolved in a small volume (20 – 50 µl) of 
1x Tris buffered saline. Protein concentrations were measured as described above. 
Protein separation with SDS-PAGE 
Freshly prepared SDS-polyacrylamide gels (10 – 16%) were loaded with 1 - 20 µg of total 
homogenate or purified myelin (in protein loading dye with 5% ß-mercapthoethanol). Only for 
detection of the myelin associated glycoprotein (MAG) non-reducing conditions were chosen. 
After focusing the proteins in the stacking gel at low voltage, protein separation was carried 
out at ~80 V using the BioRad Protein Electrophoresis device. Single proteins herein 
separated according to their charge, which corresponds to their size. 
 
Western Blotting 
Proteins were transferred to methanol activated polyvinylidene difluoride (PVDF) membranes 
by wet chamber western blotting (BioRad). Therefore sandwiches of filter, filterpapers, gel 
and membrane were inserted into the wet chamber, filled with cold transfer buffer. According 
to the size of the protein of interest, gels were blotted for 1.5 – 2 h at 80 V and 4°C. 
Afterwards, gels were incubated in Brilliant blue G250 coomassie (BioRad) to control for the 
transfer of proteins and equal loading. Membranes were subsequently blocked for 1 h in 
either 5% milk in TBST or in 5% BSA in TBST for most phosphorylated proteins. In the 
following primary antibody incubations were carried out over night at 4°C while rotating the 
membranes (For antibody dilutions see page 24). Membranes were washed four times for 
15 min in TBST to get rid of unbound primary antibodies. Afterwards appropriate secondary 
antibodies were applied for 45 min at room temperature. Following several washes with 
TBST, proteins were detected using the Western Lightning Plus-ECL-Kit (Perkin Elmer Life 
Sciences). To control for equal loading membranes were incubated with actin or GAPDH as 
internal standards. Quantifications of immunoblots were carried out using the “Gele” analysis 
plugin of ImageJ. All values were normalized to the standard proteins on the same gel. 
Quantities were displayed as relative values related to wildtype dorsal roots that were set to 
1. 
 
Silver impregnation of SDS-gels 
Silver impregnations were performed to unspecifically visualize all proteins within peripheral 
nerve lysates or purified myelin samples. Therefore, 0.5 µg proteins were loaded on freshly 
prepared SDS-gels. SDS-PAGE was performed as described above. After separation of 
proteins the gels were silver stained according to a protocol modified from Blum (1987) and 
Mortz (2001). First, gels were fixed with 40% ethanol, 10% acetic acid for 1 h and washed 
twice with 30% ethanol and once with ddH2O for 20 min each. The fixed gels were then 
incubated with sodium thiosulfate (0.8 mM) for 1 min followed by short washes in ddH2O for 
1 min in total. The gels were further impregnated with 0.2% silver nitrate (containing 0.05% 
formaldehyde solution (37%)) for 20 min and rinsed with ddH2O for 1 min. For subsequent 
chemical development the prepared gels were incubated with 3% sodium carbonate 
(containing 0.05% formaldehyde solution (37%)) until the staining was sufficient. Replacing 
the developing solution by 5% acetic acid stopped the reaction. The stainings were fixed by 




Myelin was purified from dorsal and ventral roots of adult animals (n = 3 per group). All 
samples were analyzed with silver staining to ensure equal qualities of the myelin 
preparation. The purified myelin was used for gel-free proteome analysis which was carried 
out by Dr. Stefan Tenzer at the Institute of Immunology, University of Mainz. Each sample 
was analyzed in 4 technical replicates. Thus, purified proteins were digested with trypsin to 
receive shorter peptides that have subsequently been investigated using mass spectrometry 
(LC-MS). The peptide sequences were aligned with the UniProtKB/SwissProt Protein 
Knowledgebase (mouse protein data set) for protein identification (detailed description in 
Patzig et al., 2011). The quantitative dorsal root myelin protein data were compared to data 
obtained for ventral root myelin to unravel differences in protein expression.  
 
3.7 Data analysis 
All technical replicates were combined to one mean data point for each sample. Biological 
replicates were single data points (n-numbers). For each group (time points or genotypes) 
the mean, standard deviation (SD) and the standard error of mean (SEM) was calculated. 
When the statistical comparison only included two groups (e.g. wildtype versus CNP deficient 
mice) the student’s t-test was performed using Excel 2007. Calculated p-values above 0.05 
were assigned as not significant (ns) in the diagrams. When the statistical test yielded p-
values smaller than 0.05 the comparison was considered as significantly different. P-values 
smaller than 0.05 are displayed with (*), > 0.01 with (**) and p-values below 0.001 with (***). 
When multiple comparisons had to be performed 2-way-Anova tests with Bonferroni post hoc 
test and frequency distributions were performed using GraphPad Prism vers. 5.04.  
  
3.8 Embedding protocols 
Conventional embedding of tissue in Epoxy resin protocol 
0.1 M Phosphate buffer (PB) 3x 10 min 4°C 
2% Osmium tetraoxide in 0.1 M PB 4 h 4°C 
0.1 M Phosphate buffer 3x 10 min 4°C 
30% Ethanol 20 min 4°C 
50% Ethanol 20 min 4°C 
70% Ethanol 20 min 4°C 
90% Ethanol 20 min 4°C 
100% Ethanol 3x 10 min 4°C 
2-Propanol 10min 4°C 
Propylene oxide 3x 10 min RT 
2 : 1 Propylene oxide : Epon 2 h RT 
1 : 1 Propylene oxide : Epon 2 h RT 
1 : 2 Propylene oxide : Epon 4 h RT 
pure Epon 4 h RT 
Transfer tissue from bucket to embedding molds and polymerize for 24 h at 60°C 
 
Automated freeze substitution protocol 
0.1% Tannic acid in acetone  100 h -90°C 
Icecold acetone  4x 30 min -90°C 
2% Osmium tetraoxide in acetone 7 h -90°C 
 14 h warm up to -20°C by 5°C / h 
 16 h -20°C 
 2.4 h warm up to 4°C by 10°C / h 
 1 h 4°C 
cold acetone 3x 20 min 4°C 
1 : 1 Epon : acetone 3 h RT 
90% Epon in acetone overnight RT 
Pure Epon (freshly made) 6 h RT 
Remove nerve tissue from sample carrier and place in suitable embedding mold. 
Polymerization for 24 h at 60°C. 
  
Paraffin wax embedding protocol  
50% Ethanol once 1 h 
70% Ethanol twice 2 h 
96% Ethanol twice 1 h 
100% Ethanol twice 1 h 
2-Propanol once 1 h 
Xylol twice 2 h 
Paraffin wax (60°C) twice 2 h 
 
Rehydration protocol for wax sections 
Warm up 10-20 min 60°C 
Xylene twice 10 min RT 
1 : 1 Xylene : 2-Propanol 10 min RT 
100% Ethanol 5 min RT 
90% Ethanol 5 min RT 
70% Ethanol 5 min RT 
50% Ethanol 5 min RT 
ddH20 5 min RT 
Citrate buffer 5 min RT 
Citrate buffer 10-15 min boiling in microwave 
 20 min cooling down to RT 
Tris buffered milk 5 min RT 
 
Counterstaining with hematoxylin (for wax sections) 
Mayer’s hematoxylin solution 30 s 
ddH2O shortly 
HCl-Alcohol few seconds 
ddH2O shortly 
Scotts solution 5 min 
ddH2O shortly 
50% Ethanol 5 min 
70% Ethanol 5 min 
90% Ethanol 5 min 
100% Ethanol 5 min 
1 : 1 Xylene : 2-Propanol 10 min 
Xylene twice 10 min  
4 Results 
4.1 Schwann cells form distinct myelin sheaths 
Peripheral nerves comprise all kinds of nerve fibers, ranging from very small unmyelinated 
predominantly sensory fibers to large strongly myelinated motor fibers. Associated glial cells 
are grouped into myelinating and nonmyelinating Schwann cells (SC) (Ochoa and Mair, 
1969; reviewed in Jessen and Mirsky, 2005). Within the group of myelinating SC differences 
in the expression of trophic factors and extracellular matrix components have been described 
(Höke et al., 2006; Madison et al., 2009). To date it has not been investigated if SC that wrap 
small compared to large caliber axons also differ with regard to their myelin sheath. Thus, the 
focus of this work is the comparison of the myelin sheaths of motor and sensory SC and the 
investigation of the role of specific myelin proteins for discrete fibers types. I took advantage 
of the well described separation of small and large fibers in dorsal (small / sensory) and 
ventral (large / motor) roots. To demonstrate the differences, semithin sections of wildtype 
dorsal and ventral roots were prepared as shown in Fig 1. It is easy to identify the dorsal root 
(left) that contains all kinds of sensory fibers from small unmyelinated C-fibers in Remak 
bundles, up to larger, slow and also fast conducting A-alpha, beta and delta afferent fibers. In 
contrast, ventral roots comprise large A-alpha type motor axons which are well myelinated. 
Additionally they contain a minor proportion of small A-beta and A-gamma motor neurons 
that innervate muscle spindles (FitzGerald et al., 2011).  
 
Fig 1: Dorsal and ventral roots contain different fiber types 
Semithin cross section of a wildtype dorsal and ventral root (height L4) stained with methylene blue / azure II blue, 
which displays myelin (blue) and respectively the (unstained) axons. Bottom images more clearly depict 
differences in fiber sizes of dorsal (left) and ventral (right) roots. (Scale 50 µm in overview, bottom scale 10 µm). 
4.1.1 Distinct myelin composition in dorsal and ventral roots 
Motor and sensory SC exhibit differences regarding extracellular matrix components and 
growth factors during peripheral nerve regeneration. We hypothesized that motor and 
sensory SC also differ with regard to their myelin sheaths. Initial comparison of myelin 
purified from uninjured wildtype dorsal and ventral roots of adult animals showed that the 
myelin of dorsal and ventral roots indeed display a different composition when proteins were 
visualized by silver impregnation after SDS-polyacrylamide gelelectrophoresis. The majority 
of proteins showed stronger band intensities in myelin of the dorsal roots (left arrowheads in 
Fig 2A). For example CNP, which runs at 46 kDa and 48 kDa showed a stronger signal in 
dorsal root myelin (highlighted with “CNP”). Additionally, some proteins were enriched in 
ventral root myelin (right arrowheads in Fig 2A). Mass spectrometry (MS) based quantitative 
proteome analyses furthermore displayed differentially regulated proteins. Here, the relative 
abundance of proteins purified from dorsal root myelin was compared to their abundance in 
ventral root myelin and all differentially expressed proteins were categorized regarding their 
described functions. Remarkably, these differentially expressed proteins not only comprise 
classical compact and noncompact myelin proteins, but also proteins linked to the 
cytoskeleton, cytoskeleton dynamics, enzymes and proteins related to energy metabolism of 
the cells (Fig 2B). Interestingly, in this MS based comparison the majority of identified 
proteins were significantly increased in ventral roots. Among those ventrally enriched 
proteins most seem to be of generally low abundance and may thus not be represented by 
the protein bands in the silver gels which show only relatively abundant proteins. However, 
more subtle differences as observed in this first proteome comparison may exist. These 
observations imply a general diversity within the myelinating SC population and the 




Fig 2: Purified myelin of dorsal and ventral roots displays different protein compositions 
A: Silver impregnation of a SDS-gel loaded with purified myelin from dorsal and ventral roots. Arrowheads 
highlight proteins that are more abundant in dorsal roots (left) or ventral roots (right) when comparing band 
intensities. This demonstrates a differential protein composition in motor and sensory SC (n=3 per group). 
B: Mass spectrometry based comparisons of dorsal and ventral root myelin proteomes. All proteins that are 
differentially expressed are included in the pie chart. Categorization of these proteins reveals that not only 
classical compact and noncompact myelin proteins but also proteins related to cytoskeleton, enzymes and energy 
functions display differences in their abundance in motor and sensory SC. (n=3 per group). 
  
4.1.2 Different abundance of myelin proteins in dorsal and ventral roots  
The expression levels of classical myelin proteins were further investigated on immunoblot 
level and remarkable differences were detected between myelin of dorsal and ventral roots. 
The noncompact myelin protein 2’,3’-cyclic nucleotide 3’-phosphodiesterase (CNP) displayed 
a robust difference in protein abundance with increased expression levels in dorsal roots 
(Fig 3A). In addition, Sirtuin2, which is a NAD+ dependent deacetylase (Werner et al., 2007), 
as well as Connexin29 (localized to all cytoplasmic regions of Schwann cells, Altevogt et al., 
2002) and Septin2, which is part of the Septin filament skeleton underneath the myelin 
sheath (Buser et al., 2009) appear to be elevated in dorsal compared to ventral roots. 
Differences in protein abundance were not only observed for noncompact myelin proteins but 
also among the tested compact myelin proteins. The proteolipid protein (PLP and its shorter 
isoform DM20), which is one of the most abundant myelin proteins (Garbern et al., 1997), 
was found to be even more enriched in Schwann cells surrounding small sensory fibers 
(dorsal root) compared to Schwann cells engulfing large motor fibers in the ventral root 
(Fig 3B). Of the myelin proteins tested, only the peripheral myelin protein 2 (MyP2), which is 
barely detectable in dorsal roots, showed elevated expression levels in ventral roots of adult 
wildtype animals. This is in line with findings by other groups (Kadlubowski et al., 1984). 
However, other investigated myelin proteins like Caspr, MAG, PMP22 and MBP did not show 
obvious differences in their expression levels comparing motor and sensory nerves. To 
clarify myelin protein abundance differences, band intensities were quantified. Proteins of 
interest were normalized to their respective loading control (Actin or GAPDH). Data are 
presented relative to the protein expression level in ventral roots, which was set to 1 
(Fig 3C). Among the analyzed proteins CNP showed the most robust difference in 
expression with 2.7 times higher protein levels in dorsal compared to ventral root samples. 
These data confirmed the differences that were observed in the proteome analysis. Moreover 
they prompted at CNP as a candidate protein to study the differential impact of myelin 
proteins for the integrity of distinct peripheral nerve fiber types. 
 
 
Fig 3: Distinct myelin protein abundances in dorsal and ventral roots 
A: Immunoblots of classical noncompact myelin proteins in dorsal and ventral root lysates from 6 months old 
wildtype animals. CNP shows a remarkable enrichment in dorsal compared to ventral roots. Additionally, Sirtuin2 
(Sirt2), Connexin 29 (CX29) as well as Septin2 (SEPT2) are elevated in dorsal roots. (n=3 per group). 
B: Also the classical compact myelin proteins PLP/DM20 and MyP2 display different expression levels in dorsal 
compared to ventral roots, while others (PMP22 and MPB) are of equal abundance. (n=3 per group).  
C: Relative quantification of compact and noncompact myelin protein expression levels in dorsal and ventral root 
samples from 6 months old wildtypes. CNP is 2.7 times stronger expressed in dorsal roots compared to ventral 
roots and displays highly significant differences. Also MyP2 which is barely detectable in dorsal roots shows 
robust difference in its expression with elevated levels in the ventral root. Bar diagrams are only displayed for 
myelin proteins that appeared differentially regulated on the immunoblots in A and B (highlighted in red). (n=3 per 
group; Mean + SEM). 
4.2 CNP is elevated in myelinating Schwann cells of dorsal roots 
4.2.1 Histological confirmation of increased CNP levels in dorsal roots 
CNP abundance differences have not only been detected on protein level in immunoblots but 
were further observed when peripheral nerve tissue was stained with an anti-CNP-antibody. 
Here, dorsal roots displayed numerous CNP positively labeled SC (green), which were only 
rarely observable in their ventral root counterparts (Fig 4). To unravel the specificity of the 
CNP signal for SC of different fiber populations, the CNP staining intensities were correlated 
to the size of the associated fibers. Therefore axons were visualized with the neuron specific 
beta-Tubulin III marker (Tuj1, grey), which allows to discriminate between large and small 
fibers. The vast majority of CNP positive staining was associated with small caliber axons. 
This explains, why the overall staining intensity was much stronger in dorsal compared to 
ventral roots, because the proportion of small fibers is much higher in dorsal compared to 
ventral roots. As it is easy to discriminate large and small fibers in ventral roots, a high 
magnification image of a ventral root shall illustrate the clear association of the SC specific 
CNP-signals (green) with small axons (Tuj1, staining in grey). These observations were in 




Fig 4: Staining intensity for CNP is higher in dorsal roots 
Wax sections of dorsal and ventral roots of 6 months old wildtype animals stained for CNP (green) as well as Tuj1 
(grey, to display corresponding axons) and DAPI (nuclear stain). Dorsal roots show more CNP positive areas than 
respective ventral roots. CNP stained Schwann cells are mostly associated with small caliber axons 
(magnification). (Scale bars depict 10 µm).  
 
  
4.2.2 CNP transcript levels are enhanced in dorsal root Schwann cells 
Furthermore, quantitative real time PCR (qRT-PCR) analyses comparing CNP specific 
mRNA abundances in total RNAs from dorsal and ventral root samples revealed elevated 
CNP transcript levels in dorsal root Schwann cells (Fig 5). Relative to the ventral root level, 
which was set to one, dorsal roots exhibited 55% more CNP mRNA. Thus, CNP seems to be 
differentially regulated on transcriptional and translational level, with more RNA and protein 
expressed in dorsal compared to ventral root Schwann cells. All these observations raised 
the question whether different CNP expression levels correlate with a differential impact of 
CNP function on small versus large peripheral nerve fibers.  
 
Fig 5: CNP transcript levels are elevated in dorsal roots 
A: qRT-PCR analyses of dorsal and ventral roots of 6 months old wildtypes. Dorsal roots display 55% more CNP 
specific mRNA transcripts. (n=6; Mean + SEM). 
B: qRT-PCR products specific to CNP and Actin for dorsal and ventral roots visualized on agarose gels. Single 
bands proof specificity of the reactions. 
 
 
4.2.3 Nonmyelinating Schwann cells do not express substantial CNP levels 
Among sensory axons myelinated fibers are outnumbered by unmyelinated C-fibers (Ochoa 
and Mair, 1969). C-fibers are grouped and associated with nonmyelinating Schwann cells 
that engulf and separate the axons and thus form Remak bundles. As previously described, 
CNP is robustly expressed in Schwann cells that are associated with small caliber axons in 
dorsal roots. It has not explicitly been shown if adult nonmyelinating SC expressed CNP. 
Therefore, wax sections of wildtype sciatic nerves, which contain both, myelinated and 
nonmyelinated axons, were stained with the C-fiber marker Peripherin (orange; C-fibers and 
very small myelinated fibers), as well as CNP (green) to investigate overlapping staining 
patterns. Nonmyelinating SC of Remak bundles (borders of bundles outlined in white, only 
bundles with nucleus were considered) displayed no detectable CNP-staining in their 
perinuclear cytoplasm (Fig 6). This suggests that CNP expression levels in nonmyelinating 
SC are below the limits of detection or that they do not express CNP at all. This finding was 
important for the following experiments as it argues for a specific impact of CNP for 
myelinating Schwann cells surrounding small caliber axons. Moreover, pathological changes 





Fig 6: Nonmyelinating Schwann cells show no considerable CNP expression 
Wax sections of sciatic nerves of 6 months old wildtypes immunofluorescently labeled for Peripherin (orange), 
which labels C-fibers, counterstained with CNP (green) and DAPI (blue, nuclear stain). No overlap of CNP and 
Peripherin-labeled Remak bundles can be observed. In contrast, myelinating SC associated with small caliber 
axons display a bright CNP staining (arrow), which serves as a positive control. (Scale bar represents 10 µm). 
  
4.3 Ablation of CNP influences the noncompact myelin compartment 
Taken together, all observations point towards discrete Schwann cell populations with CNP 
being robustly expressed in myelinating glial cells that are in contact with small caliber axons. 
CNP deficient mice enabled us to investigate whether the impact of CNP function varies for 
small and large fibers as suggested by the different expression levels. It has been shown that 
CNP is localized to noncompact myelin areas as Schmidt-Lanterman incisures, paranodal 
loops, the inner and outer mesaxons as well as the cell bodies of Schwann cells (Braun et 
al., 1988; Trapp et al., 1988). CNP was described as a structural protein which is in intimate 
contact with the actin and tubulin cytoskeleton as well as with membranes (Braun et al., 
1991; Bifulco et al., 2002; Lee et al., 2005). Furthermore, CNP has been shown to have an 
impact on inner tongue formation in the CNS (Edgar et al., 2009; Snaidero et al., 2014). 
Thus, we next addressed the morphology of the noncompact myelin compartment, where 
CNP is localized in the wildtype state. Analyses were mainly performed using saphenous 
nerves of wildtype and CNP deficient animals. 
 
4.3.1 Paranodal loops and Schmidt-Lanterman incisures remain unaltered 
Electron microscopic assessments of longitudinal saphenous nerve ultrathin sections did not 
show obvious alterations in the ultrastructure of paranodal loops (Fig 7A) or nodes of Ranvier 
nor in the structure of Schmidt-Lanterman incisures (SLI, Fig 7B). As it was difficult to judge 
the frequency of SLI on ultrathin nerve sections, further investigations on light microscopic 
level were carried out. To this end, teased sciatic nerve fibers were stained for the myelin 
associated glycoprotein (MAG; orange in Fig 7C) to visualize all incisures. To reliably 
recognize the dimensions of single internodes, fibers were costained for the voltage gated 
sodium channel Nav1.6 (green in Fig 7C) that labels nodes. The relation of SLIs numbers to 
the length of the axon was equal in CNP mutants and controls (Fig 7D). The thicker the fibers 
and their myelin, the more SLIs were observed in a given distance (compare different axonal 
sizes in Fig 7E). No differences were detected between wildtype and CNP deficient animals 
for any fiber type (Fig 7E). Moreover, internodal length measurements were included in this 
refined investigation of CNP deficient and wildtype nerve fibers. Therefore, teased fibers 
were stained for MBP (green in Fig 7F), which is expressed along the entire internode, as 
well as the paranodal protein Caspr (red in Fig 7F), that visualized the lateral ends of the 
internode. Internodal length measurements did not show any alteration, neither for small nor 
for large caliber axons. Thus, longitudinal dimensions of Schwann cells are not affected by 
the CNP deletion.  
 
Fig 7: Unaltered paranodal loops and Schmidt-Lanterman incisures in CNP-/- animals 
A: Electron micrographs of nodes with adjacent paranodal loops in longitudinal saphenous nerve ultrathin 
sections of 6 months old wildtype (WT) and CNP deficient animals (KO) display no differences. (Scale bars 1 µm). 
B: Schmidt-Lanterman incisures (red arrowheads) on electron micrographs of longitudinal ultrathin sections of 
saphenous nerve display a normal ultrastructure in CNP deficient animals (right) compared to wildtype controls 
(left) at 6 months of age. (Scale bars display 1 µm). (Figure legend continued on the next page) 
4.3.2 Inner tongues are smaller in the PNS of adult CNP deficient mice 
It has previously been shown that the deficiency of CNP causes swollen inner tongues in the 
central nervous system already at P5 (Edgar et al., 2009). Swellings of the inner tongue may 
interfere with the normal axon-glia interplay. High pressure frozen dorsal roots from CNP 
deficient and wildtype animals at 10 days, 1 month and 6 months of age were used to 
investigate inner tongue features in the PNS. Analyses were performed on small caliber 
axons because strongest alterations were expected for these fibers as they are associated 
with the Schwann cells that express most CNP in wildtypes. Inner tongues were categorized 
as small (left), normal (middle) or enlarged (right image) as illustrated in Fig 8A. Swollen 
inner tongues, as described for the CNS, were observed very rarely in the PNS. Unaltered 
frequencies of the three categories between WT and KO at postnatal day 10 possibly 
demonstrate that CNP function may only play a minor role in the PNS inner tongue formation 
during developmental myelination. However, in juvenile stages (1 month of age) CNP 
deficient mice displayed an increase in enlarged inner tongues, which reversed with age. 
Within dorsal roots of 6 months old animals the amount of enlarged inner tongues was 
significantly decreased whereas the number of axons with very small inner tongues 
increased. One possible explanation for the discrepancies between 1 and 6 months of age 
could be that fibers that showed enlarged inner tongues in early stages may be lost during 
adulthood. Another possibility would be that during late stages of active myelination the 
transport within the noncompact compartment might be hampered and material accumulates 
in the inner tongue (enlarged at 1 m), which is slowly released when the sheath is 
established (smaller at 6 m). However, at 6 months of age, when animals start to show 
symptoms (Lappe-Siefke et al., 2003) this specific part of the noncompact compartment was 




Continued legend from figure 7 
C: Teased sciatic nerve fibers from 6 months old wildtype and CNP deficient animals stained against MAG 
(orange, SLI, white arrowheads) and Nav1.6 (green, node, green arrowheads) as well as DAPI (blue, nuclei). 
(Scale bars represent 100 µm). 
D: Quantifications of Schmidt-Lanterman incisures (MAG staining in C) along the corresponding internodes in 
teased fiber preparations of 6 months old CNP deficient (grey) and wildtype control animals (white) show no 
significant differences. (WT n=4, KO n=6; Mean + SEM). 
E: All fibers summarized in D have further been related to the axonal diameter. Similarly no group of fibers 
showed differences in the SLI spacing in CNP mutants compared to wildtypes. (WT n=4, KO n=6; Mean + SEM). 
F: Teased fiber preparation of a 6 months old wildtype animal stained for MBP (green, myelin), Caspr (red, 
paranode) and DAPI (blue, nuclei). Bottom image illustrates how measurements from paranode to paranode were 
performed (white lines) using ImageJ. (Scale bars represent 100 µm). 
G: Quantification of the internodal length in wildtype (white) and CNP deficient animals (grey) reveals normal 





Fig 8: Smaller inner tongues in adult CNP mutants 
A: Electron micrographs of high pressure frozen dorsal root axons of 1 month old animals illustrate small, normal 
and enlarged inner tongues of SC surrounding small caliber axons. (Scale bars display 500 nm). 
B: Frequency quantification of small, normal and enlarged inner tongues as illustrated in (A) for 10 days, 1 month 
and 6 months old CNP deficient (grey) and control (white) animals. The frequency of small inner tongues 
increases with age in both genotypes. CNP deficiency causes a further decrease of inner tongue size in adult 




4.3.3 Cytoplasmic channels are less frequent in adult CNP mutants 
Cytoplamic channels, another part of the noncompact myelin network in glial cells, have 
recently been reported to be reduced when oligodendrocytes lack CNP (Snaidero et al., 
2014). The channels represent highly dynamic shortcuts through the compact myelin sheath, 
which occur in the peripheral nerves in addition to the more static Schmidt-Lanterman 
incisures. Therefore it is believed that they serve different functions. In peripheral nerves the 
number of cytoplasmic channels of 10 days old CNP deficient animals was not significantly 
different from that of wildtypes (illustrated in Fig 9A). In contrast, at 1 month of age a trend to 
a decreased amount of channels has been observed when the SC were devoid of CNP 
(p=0.07 in Fig 9B). This decline becomes manifested during adulthood. Hence, small fibers in 
high pressure frozen dorsal roots of 6 months old CNP deficient animals showed cytoplasmic 
channels less than half as often as they were observed in small caliber axons in wildtype 
dorsal root samples (Fig 9B, right bars). Together with the reduced size of inner tongues, 
these data revealed that adult CNP deficient nerves show a further reduction within the 
noncompact myelin compartment in the PNS.  
 
 
Fig 9: Cytoplasmic channels are less frequent in adult CNP mutants 
A: Electron micrograph of a small caliber axon of a wildtype high pressure frozen dorsal root at 1 month of age 
displays a cytoplasmic channel through the compact myelin sheath (outlined in red). (Scale bar of 500 nm). 
B: Cytoplasmic channel quantifications for small caliber dorsal root axons of P10, 1 month and 6 months old CNP 
deficient (grey) and wildtype (white) animals reveal a decrease of cytoplasmic channels with age and further 




4.3.4 The inner mesaxon is fully compacted in CNP mutants 
During CNS myelination the myelin sheath gets compacted towards the inner mesaxon 
finally leaving only the inner tongues filled with cytoplasm. When CNP is ablated this process 
happens faster (Snaidero et al., 2014). The actual process of compaction and the impact of 
CNP have not been investigated in the PNS so far. To this end analyses of the inner 
mesaxons of small caliber axons in high pressure frozen dorsal roots of CNP deficient and 
wildtype animals were performed. Surprisingly, there was no effect of CNP deficiency on the 
compaction states of the innermost myelin layer at postnatal day 10 (Fig 10), when CNS 
axons showed striking differences. At one month of age the frequencies of fully and partially 
compacted inner mesaxons still did not show a difference between the genotypes. On the 
other hand, SC that form a complete ring of cytoplasm in the innermost myelin layer (right 
image in Fig 10A) have more frequently been seen in CNP deficient animals compared to 
controls at one month of age. In contrast, at 6 months of age fibers with a whole cytoplasmic 
ring were observed equally seldom in controls and mutant animals. In both genotypes a 
strong increase of fibers with fully compacted inner myelin layer was observed compared to 
younger time points. Simultaneously, the proportion of small fibers that still contained 
cytoplasm in the inner myelin layer was considerably reduced when animals aged. 
Interestingly, at the age of 6 months a significant difference was further detected between 
CNP deficient and control animals. Schwann cells lacking CNP had more often a completely 
compacted inner myelin sheath, which goes along with a reduced occurrence of fibers that 
still contained cytoplasm (Fig 10B). Within the CNS an increased compaction speed has 
been described during development (Snaidero et al., 2014) which was not detectable in the 
PNS at young stages. However, an increased state of compaction was reached in peripheral 
nerves of CNP deficient animals in adulthood. Together, the increased compaction in the 
CNS and PNS suggests that CNP may equally act as spacer in oligodendrocyte and SC 
myelin. In summary the refined analyses of all noncompact myelin domains of small caliber 
peripheral fibers revealed a reduction of the compartment when CNP is absent. This may 










Fig 10: The inner mesaxon is more compacted in CNP deficient animals 
A: Electron micrographs of high pressure frozen small caliber dorsal root axons of 1 month old animals depict 
inner mesaxons which are fully “compacted”, that contain some cytoplasm (partially compacted) or that form a 
whole cytoplasmatic ring (uncompacted) underneath the compact myelin sheath. (Scale bars display 500 nm). 
B: Quantification of the frequencies of the three categories illustrated in (A) of P10, 1 month and 6 months old 
CNP deficient (grey) and control (white) animals display an increase in compaction with age and additionally 
when SC lack CNP. (from 38% in WT at 1 month to 67% for WT at 6 months and further up to 84% in KO at 
6 months; n=4-5; Mean + SEM). 
 
  
4.4 CNP deficiency causes hypermyelination of small fibers 
The absence of the noncompact myelin protein CNP provokes changes within its 
compartment also in the PNS. Even though the compaction speed during central myelination 
was altered upon CNP deficiency (Snaidero et al., 2014) the myelin sheath thickness was 
found to be normal in the central nervous system (Lappe-Siefke et al., 2003). We therefore 
next questioned if this can equally be observed in the PNS or if the compact myelin would 
follow the decrease of the noncompact myelin to keep the ratio between the two 
compartments. 
 
4.4.1 Adult onset hypermyelination of peripheral nerves in CNP mutant mice 
Surprisingly, on light microscopic level (not shown) and more clearly on electron micrographs 
of sensory peripheral nerves an increased myelin sheath thickness was detectable as 
illustrated in Fig 11A. Quantifications of the g-ratio (the relation between axonal diameter and 
the respective myelinated fiber diameter) within saphenous nerves of 6 months old CNP 
mutant mice revealed a significant reduction compared to wildtype control animals of the 
same age. Thus, against our expectations, on average the myelin sheaths were thicker in 
peripheral nerves of adult CNP deficient mice (Fig 11B). Investigations of different axonal 
subpopulations (small compared to large caliber axons) further uncovered that small caliber 
fibers displayed the most pronounced hypermyelination when CNP was ablated. On the 
other hand, fibers above 6 µm in diameter did not exhibit differences in their myelin sheath 
thickness anymore (Fig 11C right column). Even though axonal loss in the CNS has been 
shown to a small extent already in young animals (P5 in spinal cord; Edgar et al., 2009), 
CNP deficient mice appeared normal during early life but became severely affected with age 
(Lappe-Siefke et al., 2003; Wieser et al., 2013). To determine hierarchies of pathological 
changes younger animals needed to be investigated as well. To this end, the myelin sheath 
thickness was also quantified at postnatal day 5 as well as at 1 month of age. At P5 the 
myelin sheath thickness of CNP deficient animals was not significantly different from that of 
wildtype controls, even though a trend towards decreased g-ratios was already visible. In 
1 month old animals this trend reached significance for the smallest fibers, whereas the other 
fibers remained to display only trend towards an increased myelin sheath thickness. This 
means that the difference seen at 6 months of age developed in later life, when myelination 
would normally be finished. Hence, the sheath may fail to stop growing upon CNP deficiency.  
  
4.4.2 Unaltered myelin periodicity in CNP deficient animals 
An increase in myelin sheath thickness can either be caused by an alter compaction or by an 
accumulation of additional myelin wraps. To better understand the CNP function it needed to 
be discriminated between the two possibilities. Therefore, the spacing of the myelin layers of 
small hypermyelinated (1-2 µm in diameter) saphenous nerve axons of CNP deficient 
animals was compared to that of wildtypes. The periodicity of the myelin lamellae was found 
to be of wildtype level also in CNP deficient mice (Fig 11D). This implies that the 
hypermyelination described in Fig 11A-C was caused by an addition of ultrastructurally 
normal myelin wraps throughout adult life. Particularly SC associated with small caliber 
axons thus produced tremendously more myelin membranes when CNP was ablated. This 
further suggests a role of CNP as a myelination break or an adult negative regulator of 
myelination. To rule out, that the observed relative increase in compact myelin is not just 
secondary to a reduction in axonal diameters at constant myelin levels, the fiber diameters 
themselves were investigated. The average axonal diameter in 6 months old CNP mutant 
mice was not altered compared to the mean fiber size of wildtype control animals at the 
same age (Fig 11E).  
 
4.4.3 Small motor fibers are equally affected 
All aforementioned investigations of myelination states were performed on saphenous 
nerves, which contain predominantly sensory fibers. To exclude an impact of the actual 
nerve characteristic (motor or sensory) on the myelination status during CNP ablation, similar 
investigations were performed for ventral roots which contain purely motor fibers. A 
considerable increase in myelin sheath thickness was also observed for motor fibers of 6 
months old mutant mice (Fig 11F). G-ratio measurements of different axonal subpopulations 
within ventral roots revealed hypermyelination of small motor fibers just as it was seen for 
small sensory fibers in saphenous nerves of CNP deficient animals (Fig 11F diagram). 
Hence, the hypermyelination is not dependent on the axonal identity but only correlates to 
the diameter of the enwrapped fiber. Taken together, small caliber axons are 
hypermyelinated when SC lack CNP. With regard to the reduced noncompact compartment 
as shown in section 4.3 the imbalance between the two compartments is even amplified by 
the hypermyelination. This may further impair SC intrinsic and axon-glial transport processes 







Fig 11: Hypermyelination of small caliber axons in CNP deficient mice 
A: Overview electron micrographs of saphenous nerves of 6 months old CNP deficient and wildtype animals to 
demonstrate the increase in myelin sheath thickness of small caliber axons. (Scale bars of 2.5 µm). 
B: Quantification of the mean myelin sheath thickness as ratio of axonal diameter divided by myelinated fiber 
diameter (g-ratio) for wildtype (white) and CNP-/- animals (grey) at 6 months of age. Mutant mice show a 
decreased g-ratio which reflects thicker myelin. (n=3 per group; Mean, SEM and SD). 
C: Representative electron micrographs of small caliber saphenous nerve axons from wildtype and mutant 
animals at P5, 1 month and 6 months of age. g-ratios were related to the respective axonal diameter. Both 
genotypes show an increase of the myelin thick thickness with age. The myelin sheath thickness is further 
increased in small to mid-sized fibers in CNP mutants at 6 months of age. (P5 n=5/3, 1 month n=3/4, 6 months 
n=3; Mean, SEM and SD; Scale bars depict 1 µm). 
D: High magnification micrograph of myelin lamellae around small caliber axons from wildtype and CNP deficient 
saphenous nerves. The myelin periodicity is unaltered. (n=3 per group; Mean + SEM; Scale bars of 10 nm). 
E: Axonal diameter quantification of saphenous nerves from 6 months old mutant (grey) and wildtype (white) 
animals display no significant difference. (n=6 per group; Mean diameter from perimeter + SEM). 
F: High magnification electron micrographs of small caliber ventral root fibers of wildtype and CNP deficient 
animals illustrate that small motor axons are also hypermyelinated. Myelin sheath thickness quantification relative 
to the axonal diameter displays a decreased g-ratio in CNP deficient (grey) animals which is more pronounced the 
smaller the fibers are. (Scale bars of 1 µm; n=3; Mean, SEM and SD). 
  
4.4.4 No evidence for focal hypermyelination or myelination threshold shift 
In many hypermyelinating mouse mutants for example in Dlg1, PTEN or PMP22 mutants 
(Cotter et al., 2010; Goebbels et al., 2012; Adlkofer et al., 1995) one special feature is the 
appearance of focal hypermyelination. During all electron microscopic assessments of CNP 
deficient mice and wildtype controls for this work myelin tomacula and inclusions, as well as 
outfoldings were observed very rarely. When quantifying their frequency no significant 
difference was detectable between CNP deficient mice and wildtype controls (Fig 12A-B). 
Apart from focal hypermyelination some glial mutations cause sorting defects and 
myelination threshold shifts which for instance mean, that fibers smaller than 1 µm in 
diameter are sorted and myelinated during development (Guo et al., 2013; Taveggia et al., 
2005). Saphenous nerve investigations in 6 months old CNP mutants and respective controls 
did not show differences in the threshold axonal size for myelination (Fig 12C). That distinct 
CNP-loss-of-function phenotype compared to other hypermyelinating mouse models imposes 
different underlying mechanisms that trigger the increased myelin growth. 
 
 
Fig 12: No focal hypermyelination and unaltered myelination threshold 
A: Electron micrographs of myelin tomacula (left) and myelin inclusions (right), that can be observed as frequently 
in saphenous nerves of 6 months old CNP-/- (grey) animals as in wildtype controls (white) of the same age 
(related to total axonal counts). (n=6; Frequency + SEM; Scale bars depict 2.5 µm). 
B: Representative electron micrograph of a myelin outfolding (arrowhead). Frequency quantifications show no 
significant differences between wildtype (white) and CNP deficient animals (grey) at 6 months of age. Outfoldings 
are only very rarely visible and especially in the wildtype group a high variability in their frequencies is observed. 
(n=6; Frequency + SEM; Scale bar of 2.5 µm). 
C: Electron micrograph of a myelinated axon below 1 µm in diameter. Quantifications of these fibers show no 
significant changes in the myelination threshold in CNP deficient mice at 6 months of age (grey) compared to age 
matched wildtype controls (white). (n=6; Frequency + SEM; Scale bar depicts 2.5 µm). 
4.4.5 Molecular alterations caused by the CNP deficiency 
The most remarkable effect on peripheral nerves of CNP deficient mice was the 
hypermyelination of small caliber axons. To unravel underlying mechanisms responsible for 
the ongoing myelination in adult life, peripheral nerves were further investigated on molecular 
level.  
 
4.4.5.1 No obvious alterations of the transcriptional control of myelination 
CNP overexpressing mouse mutants show a shifted peak of myelin gene expression. They 
display highest levels of myelin protein specific mRNA transcripts at two weeks of age 
compared to the normal peak at 3 weeks in control animals (Gravel et al., 1996). On the 
other hand, CNP deletion may delay the peak in myelin gene expression out of the critical 
myelination window. This might impair the end of myelination and could therefore explain the 
continous myelination especially in sensory nerves. To test this hypothesis, myelin specific 
RNA profiles were generated in a timeline from postnatal day 5 to 12 months of age for 
dorsal and ventral root tissue (Fig 13). In general, CNP specific mRNA levels as well as 
those of PLP were found to be higher in dorsal compared to ventral roots. Other myelin 
specific transcripts (P0, MBP and MAG) on the other hand showed relatively equal 
abundances. Against expectations CNP deficient tissue did not show obvious alterations of 
the RNA profiles compared to wildtype nerve samples. Only MBP and MAG transcripts were 
slightly but not significantly increased in mutant nerves. None of the tested genes showed a 
shifted peak of expression. Especially after one month of age when additional myelin is 
accumulated in CNP deficient animals no differences were observed. This suggests that the 
hypermyelination provoked by CNP deficiency is caused posttranscriptionally.  
 
 
Fig 13: Myelin specific mRNA profiles are unaltered when CNP is ablated 
Dorsal (upper row) and ventral root (lower row) mRNA profiles for CNP, PLP, P0, MBP and MAG in wildtype 
animals (black) and CNP mutants (red). Animals were analyzed at P5, P10, P20, P30, 2 months, 6 months and 
12 months of age. The peak in myelin gene expression can be observed at 3 weeks of age in mutants and 
controls. No significant differences of RNA expression levels can be detected at any time point between wildtype 
and CNP-/- mice. (n=4 per group and time point; Mean + SEM). 
4.4.5.2 CNP deficient mice display activated signaling pathways 
The MEK/ERK and PI3K/AKT pathways are known to influence myelination especially by 
translational control. Alterations within these signaling pathways can provoke myelination 
defects in either direction (Taveggia et al., 2005; Newbern et al., 2011; Ishii et al., 2013; 
Sheean et al., 2014). Investigation of these pathways within CNP deficient mice on 
immunoblot level revealed alterations for both pathways. To gain insight into the activity state 
of the signaling pathways the ratio between phosphorylated and unphosphorylated protein 
isoforms has to be considered. However, during development (1 month of age) only minor 
changes in phosphorylated protein isoforms relative to the unposphorylated protein levels 
were observed for MAPK and AKT (Fig 14A). Contrary, immunoblot analyses of adult 
animals (6 months of age) revealed that both pathways show an increase in their active 
isoforms pMAPK and pAKT relative to the unphosphorylated proteins in dorsal roots of CNP 
deficient animals compared to wildtype controls (Fig 14B). Single pathway activation may 
induce demyelination and dedifferentiation of SC as shown for adult Raf activation (MAPK 
pathway; Napoli et al., 2012). Interestingly, the ratio of both pathways (MAPK signaling / 
AKT signaling) remained unaltered as relative levels of phosphoproteins increased similarly 
(Fig 14B right diagram) in dorsal roots of 6 months old CNP deficient animals. The balanced 
upregulation of both pathways probably prevents disadvantageous effects that have been 
observed if only one pathway was deregulated. Instead, it may drive the ongoing myelination. 
 
4.4.5.3 Increased expression of myelin specific and lipid related proteins 
The balanced increase in MAPK and AKT signaling in adult sensory nerves potentially 
caused enhanced myelin production in a developmental fashion. Indeed, myelin basic protein 
(MBP) as well as peripheral myelin protein 2 (MyP2) were found to be increased upon CNP 
deletion in adult dorsal roots as shown on immunoblots in Fig 15A. Apart from their specific 
protein constitution, myelin membranes are especially rich in lipids. Additionally, qRT-PCR 
analysis revealed an increase of HmgCoA-reductase, the key regulator of lipid synthesis 
(Basson et al., 1988), and SCAP, which is involved in regulation of lipid transport (Verheijen 
et al., 2009), on mRNA level in dorsal roots of CNP mutant mice (Fig 15B). Together, this 
data pointed to enhanced myelin protein and lipid production in adulthood when Schwann 
cells are devoid of CNP. It has to be further investigated if this induction of myelin protein and 
myelin lipid production is actually downstream of the increased MAPK and AKT activity.  
 
Taken together, CNP deletion has no impact on transcriptional regulation of myelination and 
may therefore cause posttranscriptional alterations within the Schwann cells. However, CNP 
ablation activated MAPK and AKT signaling which may enhance adult myelin production 





Fig 14: Activation of MAPK and AKT signaling in CNP deficient nerves 
A: Immunoblots specific to MAPK and AKT and their respective phosphorylated isoforms from dorsal root 
samples of wildtype and CNP deficient animals at 1 month of age. Quantifications of the protein abundances 
display a trend to less activated MAPK signaling in CNP deficient animals (grey) compared to wildtype mice 
(white), whereas no difference is detectable for AKT and pAKT. (n=3; Mean + SEM). 
B: Similar immunoblots as in A for dorsal roots of 6 months old CNP deficient (grey) and wildtpye animals (white). 
Analyses of the phosphorylated isoforms related to the abundance of the non-phosphorylated proteins reveal a 
2.5-fold upregulation of pMAPK and pAKT levels. The ratio between the pathways remains unchanged (right 















Fig 15: Increase of myelin proteins and lipid related genes in adult CNP-/- mice 
A: Immunoblot analyses of myelin proteins CNP, MyP2 and MBP from dorsal roots of wildtype and CNP deficient 
mice. Quantifications reveal around 50% increased protein levels in 6 months old CNP mutants (grey) compared 
to wildtype controls (white). (n=3; relative values + SEM).  
B: Quantitative RT-PCR data of 6 months old CNP-/- (grey) and wildtype (white) animals display about 50% 








4.5 Impact of CNP deficiency for small caliber axons  
All aforementioned observations specifically point to an impact of CNP function for Schwann 
cells that engulf small caliber axons. Especially the proportion of noncompact and compact 
myelin was strikingly altered for small caliber fibers. In adult life CNP deficient animals 
displayed a reduction of the noncompact myelin compartment which hints to narrowed 
transport routes. Additionally, an increase in compact myelin was observed, which further 
enhances the imbalance of the two compartments. It was further investigated if the 
pathological alterations within the SC secondarily impair the integrity of underlying axons. 
 
4.5.1 Adult onset loss of small caliber axons 
During development myelinating Schwann cells enwrap and myelinate peripheral axons. 
Furthermore, it has been proposed that they trophically and metabolically support their 
underlying axons. As already described, CNP deficiency particularly led to changes in 
Schwann cells associated with small caliber axons. We next asked if these alterations within 
the SC influence the axonal integrity. When analyzing the quantity of myelinated axons within 
several peripheral nerves in adult animals (6 months of age), it became obvious that during 
adulthood CNP deficient animals displayed reduced numbers of intact myelinated fibers. The 
mixed sciatic nerve showed only slightly reduced fiber numbers (4% decrease in Fig 16A). In 
contrast, the predominantly sensory saphenous nerve (7% decrease in Fig 16C at 6 months) 
as well as the purely sensory dorsal roots (10% decrease in Fig 16B left) displayed more 
striking differences. However, no alteration of myelinated fiber numbers were observed for 
the purely motor ventral roots (Fig 16B right). To relate the axonal damage to the alterations 
within the SC younger animals had to be analyzed. Time course experiments on saphenous 
nerves of wildtype and CNP deficient animals from postnatal day 5, up to 6 months of age 
revealed differences only for the 6 month time point (Fig 16C), suggesting that the axonal 
loss appeared secondary to changes within the SC which were already existing at 1 month of 
age. To unravel if a specific axonal subpopulation is prominently lost, axonal frequency 
quantifications on saphenous nerves of 6 months old animals were carried out. The 
frequency plots did not show differences regarding the axonal size distribution between 
wildtypes and CNP mutants (Fig 16D). Therefore a loss of sensory fibers most likely affects 
all subpopulations. A prerequisite for normal amounts of myelinated fibers is a sufficient 
amount of myelinating Schwann cells. Therefore myelinating Schwann cell numbers were 
quantified. No alterations were detected in the amount of Schwann cell nuclei within 
saphenous nerves of 6 months old CNP deficient animals when compared to age matched 
wildtype controls (Fig 16E).  
  
 
Fig 16: CNP deficiency causes adult onset sensory axonal loss 
A: Quantification of myelinated fibers on sciatic nerve semithin cross sections of 6 months old wildtype (white) 
and CNP deficient animals (grey) reveals 4% loss of fibers. (n=5; Mean + SEM).  
B: Representative image of a methylene blue / azur II blue stained semithin cross section of wildtype dorsal (DR) 
and ventral (VR) roots. Myelinated fiber numbers were quantified in wildtype (white) and CNP deficient animals 
(grey). Only dorsal roots display around 10% reduced myelinated fiber numbers, whereas no difference was 
detectable in ventral roots (n=7-8; Mean + SEM; Scale bar of 100 µm). 
C: Time course of myelinated fiber loss from P5 to 6 months old CNP deficient animals (red) compared to 
wildtype controls (black) in saphenous nerves shows a significant difference only in adult animals (7%). (P5 n=5; 
1m n=4; 6m n=6; Mean + SEM). 
D: Axonal diameter measurements in saphenous nerves of 6 months old CNP-/- mice (red) and appropriate 
controls (black) show a normal frequency distribution also when CNP is deleted. (WT and KO n=6; Mean 
frequency of different axonal diameter groups and SD; column factor = 0.26). 
E: Representative electron micrograph of a myelinating Schwann cell and its nucleus (N) in an adult saphenous 
nerve. Quantification of myelinating SC nuclei in 6 months old CNP-/- animals (grey) and age matched wildtype 
controls (white) show equal nuclei numbers. (n=6; Mean + SEM; Scale bar of 2.5 µm).  
To further investigate if reduced myelinated fiber numbers in 6 months old CNP deficient 
animals actually reflect a loss of fibers or if the axons just fail to properly myelinate, but can 
be found as intact axons, refined investigations of unmyelinated axons larger than 1 µm in 
diameter were performed. Big unmyelinated axons appear as nodal profiles (A), sorted big 
unmyelinated axons (B) and big axons in Remak bundles (C in Fig 17). These profiles were 
observed as rarely in CNP deficient animals as in wildtype controls when quantified in whole 
saphenous nerves on electron microscopic level (Fig 17A-C). Total numbers were below 1%. 
This suggests that the reduced myelinated fiber numbers indeed reflect a loss of fibers 
during adult life. In contrast to the CNS, axonal swellings were not observed more frequently 
in CNP deficient peripheral nerves (Fig 17D). This indicates a slow progressive but 
continuous loss of fibers. 
 
 
Fig 17: Unaltered frequency of big unmyelinated axons 
A: Representative electron micrograph of a nodal cross section (arrowhead) in a conventionally fixed adult 
saphenous nerve. The quantification of total nodal numbers in 6 months old CNP deficient animals (grey) shows 
no difference to age matched controls (white). (n=6 per group; Mean + SEM; Scale bar of 2.5 µm). 
B: Representative electron micrograph of an unmyelinated axon above 1 µm in diameter (arrowhead) in an adult 
saphenous nerve. Sorted but unmyelinated fibers come into view equally frequent in 6 months old CNP-/- animals 
(grey) and age matched wildtype controls (n=6; Mean of total counts + SEM; Scale bar of 2.5 µm). 
C: Representative electron micrograph of a Remak bundle containing an unsorted axon above 1 µm in diameter 
(arrowhead) in an adult saphenous nerve cross section. No difference could be detected in total numbers of big 
unsorted axons in 6 months old CNP deficient animals (grey) and age matched wildtype controls (white) (n=6; 
Mean of total counts + SEM; Scale bar of 2.5 µm). 
D: Representative electron micrograph of an axonal swelling (arrowhead) in an adult saphenous nerve. Total 
numbers of the rarely observable axonal swellings in 6 months old CNP-/- animals (grey) and age matched 
wildtypes (white) are equal. (n=6; Mean of total counts + SEM; Scale bar of 2.5 µm). 
4.5.2 Remak bundles remain unaffected by CNP deficiency 
When speaking about sensory axonal loss or pathological alterations within SC of small 
caliber axons, it should be considered that the majority of sensory axons are unmyelinated 
C-fibers in Remak bundles that are associated with nonmyelinating SC. Even though adult 
nonmyelinating Schwann cells seem to express no or only very little CNP (see Fig 6) it 
should be excluded, that these fibers are affected, as their functionality is evenly crucial for 
peripheral nerve integrity. Refined analysis of CNP deficient saphenous nerves on electron 
microscopic level demonstrated that their Remak bundles are indistinguishable from those of 
wildtype controls at an age of 6 months. Bundle sizes (Fig 18B) as well as the quantities of 
axons that were improperly shielded from the endoneurium (Fig 18D) or their neighbouring 
axons (Fig 18E) were equal in mutants and controls. In line with that, the amount of 
nonmyelinating Schwann cells in CNP deficient animals showed wildtype levels as well 
(Fig 18C). An involvement of nonmyelinating SC in the pathological alterations in CNP 







Fig 18: Remak bundles remain unaltered 
A: Representative electron micrograph of a Remak bundle 
of a 6 months old wildtype saphenous nerve. Red stars 
highlight axons that are not completely insulate from the 
endoneurial space, whereas blue triangles depict axons 
that are incompletely separated from each other. (Scale bar 
represents 1 µm). 
B: Quantifications of the total number of axons per Remak 
bundle show no differences in bundle size in 6 months old 
CNP deficient animals (grey) compared to wildtype controls 
(white). (n=3; Mean + SEM). 
C: The amount of nonmyelinating Schwann cell nuclei, 
quantified in saphenous cross sections of 6 months old 
CNP mutants (grey), is equal to that of age matched 
wildtype controls (white). (n=6; Mean + SEM).  
D: Frequency quantification of axons that are not 
completely shielded from the endoneurium (red stars in A). 
CNP deficient mice (grey) and controls (white) display equal 
frequencies. (n=3; Mean + SEM).  
E: Quantifications of axons that are in direct contact to their 
neighbours show similar frequencies in wildtypes (white) 
and CNP mutant mice (grey). (n=3; Mean + SEM). 
4.5.3 No indication of inflammation within peripheral nerves of CNP mutants 
In the central nervous system of CNP deficient mice neurodegeneration is accompanied by a 
severe neuroinflammation (Lappe-Siefke et al., 2003; Wieser et al., 2013). The PNS also 
displayed axonal degeneration which could potentially trigger an inflammation. An acute 
inflammation may on the other hand further enhance the axonal degeneration. However, 
immunohistological stainings for invading macrophages (MAC3) and a T-cell response (CD3) 
within peripheral nerves displayed equal amounts of positively labeled (brown) nuclei in 
6 months old CNP mutant mice and wildtype controls. Both, the MAC3 (Fig 19A) and the 
CD3 staining (Fig 19B) exhibited low amounts of inflammatory cells in peripheral nerves. 
Contrary to the CNS, axonal loss in the peripheral nervous system was not accompanied or 
triggered by a neuroinflammation.  
 
Fig 19: No indication of inflammation within the PNS of CNP deficient animals 
A: Wax sections of sciatic nerves of 6 months old wildtype animals DAB stained for MAC3, a marker for 
macrophages. Left, overview image and on the right a magnification that illustrates the quantified MAC3 positive 
cells. Quantifications show equally low amounts of MAC3 positive cells in wildtype (white) and CNP deficient 
(grey) animals. (WT n=5, KO n=7; Mean + SEM; scale bars represent 100 µm (left) and 10 µm (right)). 
B: Wax sections of sciatic nerves of 6 months old wildtype and CNP-/- animals stained with the T-cell marker 
CD3. On the left an overview image of a stained sciatic nerve and on the right a magnification of a CD3 positive 
cell. Quantifications show that CD3 positive cells are as rare in CNP mutants (grey) as in wildtype controls (white). 
(WT n=5, KO n=7; Mean + SEM; scale bars represent 100 µm (left) and 10 µm (right)). 
4.5.4 CNP deficient animals display altered sensory nerve characteristics 
Myelin represents a high resistance electrical insulation for axons to increase conduction 
speed through saltatory impulse propagation. The myelin sheath geometry is believed to be 
optimized for maximal conduction speed (Donaldson and Hoke, 1905; Smith and Koles, 
1970; Waxman, 1980). Hence alterations within the myelin sheath may influence electrical 
nerve characteristics. To this end, electrophysiological assessments on sciatic and 
respective tibial nerves were performed for adult CNP deficient and wildtype animals. Neither 
motor nerve conduction velocity (mNCV) nor the evoked compound muscle action potentials 
(CAMPs) within the small plantar foot muscles were altered in adult CNP deficient animals 
(Fig 20A-C). In contrast, sensory nerve potentials tend to be decreased and the sensory 
NCV was shown to be slightly slower in peripheral nerves of adult CNP deficient animals 
compared to age-matched controls (Fig 20D-F). Most probably the slowing in sensory 
conduction velocity was due to the altered myelination of small caliber axons. The reduced 
amount of sensory axons may have an impact on electrical characteristics of the nerve and 
may explain the trend to a decrease in sensory potentials.  
 
4.5.5 CNP mutants display impaired sensation 
All aforementioned findings implicate alterations in sensory nerve fibers. If these alterations 
lead to a general impairment within the PNS functionality and influence the sensation of 
CNP-/- mice was so far unknown. To this end we examined motor and sensory functionality 
using independent behavioural tests. The grid slip and bar test involve higher motor 
coordination, whereas the grip strength test resembles grasping reflex behaviour paired with 
muscle power. Within the grid slip and bar tests (Fig 21A-B) 8 months old CNP deficient 
animals displayed apparent difficulties reflected in more slips and dramatically shorter 
holding times on the bar. As those two tests depend on higher motor coordination, an effect 
of the CNS, which is severely affected at that age, cannot be excluded. In contrast, CNP 
deficient animals had no difficulties within the grip strength test (reflex arch with minimal CNS 
involvement) which was in line with the unaltered large motor fibers (Fig 21C). On the other 
hand, the mechanical and thermal plantar tests may also resemble reflex related behaviour 
(avoidance reflex) but here the sensory component was addressed. Both tests showed 
significantly longer latency for paw withdrawal (Fig 21D-F) in CNP deficient animals 
compared to wildtype controls. The hyposensitivity seems to be the result of the disturbed 
integrity of sensory (small) peripheral nerve fibers. Therefore we conclude that CNP 
deficiency not only causes alterations within the SC, but secondarily impairs axonal integrity 
and subsequently affects the whole organism.  
 
 
Fig 20: Altered electrophysiological characteristics of CNP deficient peripheral nerves 
A: Trace of intramuscular recordings after distal and proximal sciatic / tibial nerve stimulation. Amplitudes are 
highlighted in red and the latency difference between the two recordings (blue) allowed the calculation of the 
nerve conduction velocity (latency / distance of electrodes). (time scale 1 ms; amplitude scale 10 mV / Division). 
B: Electrophysiological assessment of wildtype (white) and CNP deficient animals (grey) at 8 months of age 
display no significant changes of amplitudes after distal or proximal stimulation. (n=6; Mean + SEM). 
C: Motor nerve conduction velocities are indifferent between CNP deficient (grey) animals and controls (white) 
with 8 months of age. (n=6; Mean + SEM). 
D: Example of a sensory trace (peaks are the stimulation artifacts). Difference of maximum and minimum of the 
recording resembles the amplitude of the sensory nerve potential (red). The sensory nerve conduction velocity is 
calculated from the latency of the signal (blue) and the distance of the electrodes (time scale 0.5 ms; amplitude 
scale 40 µV / Division). 
E: The quantification of the sensory nerve potential after distal stimulation, shows a trend towards reduced nerve 
potentials in 8 months old CNP deficient animals (grey) compared to controls (white) but measurements are very 
variable. (WT n=7, CNP-/- n=6; Mean + SEM). 
F: The sensory conduction velocity, calculated from the latency of response (blue) and the distance of the 
electrodes, displays 21% slower conductance in CNP deficient animals (grey) at 8 months of age. (WT n=7, CNP-
/- n=6; Mean + SEM). 
 
Fig 21: Impaired sensation and higher order motor coordination 
A: Mouse performing on a grid (grid size 1 x 1 cm). Quantification of slips along the 2 m grid show more than 
double the amount of slips for 8 months old CNP deficient animals (grey) compared to wildtype controls (white). 
(WT n=7, KO n=5; Mean + SEM). 
B: Experimental animal performing on a bar. CNP deficient mice (grey) with 8 months of age are hardly able to 
stay on the bar compared to controls (white) at the same age. (WT n=7, KO n=5; Mean + SEM). 
C: Mouse grabbing the horizontal bar and investigator pulling it away to perform the grip strength test. 
Quantifications of this grasping reflex behaviour (together with the actual muscle power) show no alteration in 
CNP deficient animals (grey) compared to controls at 8 months of age (white). (WT n=7, KO n=5; Mean + SEM). 
D: Mouse in the plantar aesthesiometer setup prepared for mechanical plantar testing. 
E: Quantification of the mechanical force that is needed to provoke foot withdrawal reveals that 8 months old CNP 
deficient animals (5.7x g-force; grey) respond only to higher forces compared to age matched wildtype controls 
(3.9x g-force; white). (WT n=14, KO n=21; Mean + SEM).  
F: Quantification of withdrawal latencies after constant thermal stimulation of the plantar surface display 2 s 
longer irradiation times to initiate paw withdrawal in 8 months old CNP deficient mice (grey) compared to the 
control group (white). (WT n=14, KO n=16; Mean + SEM).  
In summary, it was shown that Schwann cells display different molecular compositions of 
their myelin sheaths according to the size of the underlying axons. Remarkable differences 
were observed for the CNP protein abundance, which was elevated in SC associated with 
small caliber axons. Ablation of CNP induced a reduction of the noncompact myelin 
compartment and drives hypermyelination in adult animals. These alterations were 
particularly pronounced in Schwann cells that normally express most CNP. Consequently, 
these SC displayed the most prominent imbalance of the two compartments. This likely 
deteriorated intracellular and transcellular transport processes which potentially have 
impaired the axonal support. Subsequently, this may have caused the observed axonal loss 
of small caliber axons, which possibly led to the sensory impairment. 
  
5 Discussion 
The peripheral nervous system (PNS), which connects the central nervous system (CNS) 
with all peripheral organs, consists of heterogeneous peripheral axons and their associated 
Schwann cells (SC). Peripheral nerve fibers are usually classified with respect to their 
direction of signal transduction, diameter, existence of a myelin sheath and conduction speed 
(FitzGerald et al., 2011). Signaling direction and diameter are neuron intrinsic characteristics 
whereas the formation of a myelin sheath and the conduction speed are mainly defined by 
the associated Schwann cells. Small fibers below 1 µm in diameter together with 
nonmyelinating SC are referred to as Remak bundles. All remaining fibers ranging from small 
sensory fibers barely above 1 µm in diameter up to large motor axons are enwrapped by 
myelinating SC that form the compact myelin sheath. Differences within the population of 
myelinating SC have previously been reported in peripheral nerve regeneration studies that 
revealed a preferential reinnervation. These observations were attributed to the different 
molecular architectures of the extracellular matrices and the individual expression of trophic 
factors by denervated motor and sensory SC (Höke et al., 2006; Madison et al., 2009; 
Brushart et al., 2013). It was not yet investigated if motor and sensory SC express 
differences with regard to their myelin sheaths in uninjured nerves. Therefore, this work 
aimed to identify developmentally established differences in the myelin sheath composition 
between myelinating SC subpopulations. The second and major part of this work addresses 
the impact of the differentially expressed noncompact myelin protein CNP on distinct 
peripheral nerve fiber types. CNP is involved in axonal support independent of myelination 
within the CNS and has been shown to influence the process of compaction during CNS 
development (Lappe-Siefke et al., 2003; Snaidero et al., 2014). To uncover the functional 
relevance of CNP within Schwann cells, peripheral nerves of CNP deficient mice were 
investigated with special emphasis to distinct fiber types.  
 
5.1 Schwann cells are diverse 
In vitro- as well as regeneration studies on motor and sensory nerves indicated that Schwann 
cells express discrete “motor” and “sensory” phenotypes specifically promoting the outgrowth 
and regrowth of appropriate motor or sensory axons during development and peripheral 
nerve regeneration. This capacity was related to the differential expression of trophic factors 
and extracellular matrix proteins (Brushart, 1993; Höke et al., 2006; Hu et al., 2010). The 
phenotypic memory of dedifferentiated SC (Büngner repair cells) will only be lost during 
prolonged denervation or by artificial expansion of the SC in vitro. Apart from trophic factors, 
several myelination and signaling related genes displayed differences in rat motor and 
sensory nerve RNA profiling studies (Jesuraj et al., 2012). This indicated a more general 
diversity of SC beyond the expression of trophic factors. One crucial task of a SC is the 
formation of the myelin sheath which needs to be tightly regulated according to the specific 
axon. Therefore we hypothesized, that myelinating SC are not uniform but that their myelin 
constitution is precisely adjusted to axonal demands. Hence, the first aim of this work was 
the investigation of individual myelin characteristics of different fiber types as they have been 
described for the just mentioned trophic factors and extracellular matrix proteins. To this end, 
myelin that was purified from SC of mainly large caliber motor axons (ventral roots) was 
compared to dorsal root myelin (sensory predominantly small caliber axons). Numerous 
differentially regulated proteins were observed in silver impregnations (Fig 2A) of purified 
myelin. This was confirmed by comparative mass spectrometry based dorsal and ventral 
myelin proteome analyses and additional immunoblot investigations for classic compact and 
noncompact myelin proteins. Apart from classical myelin proteins also several proteins 
related to metabolism or cytoskeleton, that just recently have been linked to myelin (Jahn et 
al., 2009; Patzig et al., 2011; Monasterio-Schrader et al., 2012), displayed differential 
expression levels (Fig 2B). Among the unequally expressed proteins, CNP revealed the most 
robust difference in protein abundance. These data suggest that SC are not only different 
with regard to the constitution of their extracellular matrices and the expression of trophic 
factors but also show a striking variability in their myelin sheath composition. In contrast to 
the reported differences in peripheral nerve regeneration, the newly observed variability in 
the myelin stoichiometry must have been established during SC development and is 
maintained throughout life. We speculate that the myelin specific differences are at least 
partially regained during SC redifferentiation and remyelination even though the myelin 
sheath never reaches the original sheath thickness in regenerating peripheral nerve fibers 
(Schröder, 1972). Altogether, this points to a general diversity of myelinating SC, which may 
enable them to individually match axonal demands. Furthermore, differences in dimensions 
of the myelin sheaths of small and large caliber axons may require an optimized relation of 
the compartments to enable efficient transport within the SC and among the SC-axon-
interface. Thus, we believe that myelinating glia and their underlying axon are much more 
synchronized than so far assumed. 
 
  
5.2 CNP is enriched in SC surrounding small caliber axons 
Among the investigated myelin proteins the most robust discrepancy in motor and sensory 
expression was observed for the noncompact myelin protein CNP. Quantitative immunoblot 
examinations revealed 2.7 fold higher protein abundance in dorsal root myelin compared to 
myelin harvested from ventral roots (Fig 3). This dissimilarity was confirmed by 
immunohistological assessments of dorsal and ventral roots, which similarly showed stronger 
expression of CNP in myelinating SC surrounding small caliber axons (Fig 4). Thus, 
enhanced signal intensities can be found in dorsal roots because of the proportion of small 
caliber axons which is much higher in dorsal compared to ventral roots. However, also small 
caliber fibers in the ventral roots display enhanced CNP expression levels. Hence, it can be 
concluded that the total CNP expression levels inversely correlates to the fiber diameter 
independent of the motor or sensory identity of the engulfed axon. As proposed for the CNS, 
CNP may be involved in axonal support independent of the myelin sheath also in the PNS 
(Lappe-Siefke et al., 2003; Nave, 2010a). In the CNS small caliber axons have repeatedly 
been reported to be more effected by pathologic alterations within the myelinating glia 
(Griffiths et al., 1998; Evangelou et al., 2001; Edgar et al., 2004, 2009). Thus, small caliber 
axons seem to be more vulnerable to subtle changes within the axon-glia interplay. One 
possible reason may be that they have higher demands for metabolic and trophic support as 
they seem to have the lowest storage capacities. This implies that also SC surrounding small 
caliber fibers may have to support their axons more intensely. CNP is proposed to be directly 
involved in axonal support and therefore elevated CNP levels may resemble SC’s adequate 
response to enhanced trophic demands by small caliber axons. Interestingly, we could not 
detect CNP in nonmyelinating SC that engulf C-fibers in Remak bundles (Fig 6). This 
suggests that mature nonmyelinating SC do not express CNP, or that the level of expression 
is very low. However, during early development, most probably in the immature SC stage, 
also cells that gave rise to nonmyelinating SC must have expressed CNP as indirectly shown 
by CNP-Cre-driven molecular alterations that also affect Remak bundles. A good example is 
the CNP-Cre mediated ablation of PTEN which causes aberrant SC wraps around C-fibers, 
indicating that nonmyelinating SC were indeed reprogrammed using the CNP-specific 
promotor activities to drive Cre recombination (Goebbels et al., 2010). If CNP acts as a 
spacer to keep myelin sheaths uncompacted as seen in development (Snaidero et al., 2014) 
and upon CNP overexpression (Gravel et al., 1996), this function may have been abandoned 
during maturation of nonmyelinating SC as there is no compact sheath in nonmyelinating SC. 
Nevertheless, CNP is one of the earliest markers within the SC lineage (Scherer et al., 1994) 
and additional functions of CNP, probably the catalytic function, may be crucial in early 
development of nonmyelinating as well as myelinating SC.  
5.3 CNP affects the noncompact and compact myelin compartment 
2’,3’-cyclic nucleotide-3’-phosphodiesterase (CNP) is not only expressed in SC but also in 
oligodendrocytes within the CNS. Former investigations of CNP in the nervous system 
revealed that it is localized to all uncompacted myelin domains: paranodal loops, inner and 
outer mesaxons, the perinuclear cytoplasm and in the PNS also to Schmidt-Lanterman 
incisures. Therefore CNP belongs to the group of classic noncompact myelin proteins (Braun 
et al., 1988; Trapp et al., 1988). Within the developing CNS, CNP seems to carry out mainly 
structural functions in organization and maintenance of noncompact myelin regions but also 
influences the compact myelin sheath. Thus CNP overexpression severely impairs 
compaction due to an overload of CNP within the sheath which simultaneously hampers 
MBP pathfinding and thus the compaction of the myelin lamellae. Additionally, CNP 
overexpression induces aberrant myelin production (Gravel et al., 1996; Yin et al., 1997). 
This suggests CNP as a spacer within growing myelin, which normally gets coordinatedly 
subtracted and thus allows zipping of the myelin layers by MBP. Moreover, recent 
investigation by Snaidero and coworkers (2014) supported this hypothesis as the compaction 
speed was significantly increased in CNP deficient mice. Additional proof for an important 
role of CNP for the noncompact myelin integrity was given by the frequent observation of 
swollen inner tongues and disorganized paranodes in CNP deficient animals in the CNS 
(Rasband et al., 2005; Edgar et al., 2009). Together, these findings imply a critical 
involvement of CNP in noncompact myelin organization. Interestingly, even though CNP 
deficient mice develop a severe white matter atrophy and astrogliosis, the compact myelin 
sheath within the CNS appeared normal. This led to the assumption that CNP plays an 
important role in myelin independent axonal support (Lappe-Siefke et al., 2003; Nave and 
Trapp, 2008; Nave, 2010a, 2010b). The role of CNP in SC and its importance for PNS 
integrity has not been previously investigated. The striking differences in CNP protein 
abundance in different fiber types found in this study helped to uncover the impact of CNP 
function for different peripheral nerve fiber types. Initial investigations addressed the 
noncompact myelin, the compartment that normally comprises CNP. In line with reported 
increased compaction speed and a decrease in cytoplasmic channel frequencies (Snaidero 
et al., 2014) also SC display a reduction in noncompact myelin regions as inner mesaxon, 
cytoplasmic channels and inner tongues (Fig 7, 9, 10). Contrary to findings in the CNS, these 
observations were made in adult PNS tissue, whereas young CNP deficient peripheral 
nerves were largely unaltered. This pointed to a greater role of CNP for maintenance of SC 
integrity than for its impact on SC development. All findings point to a constricted 
noncompact myelin network whose functionality is pivotal for innermyelinic transport 
processes. Inner tongues, the actual axon-glia interface, were found to be smaller in the PNS 
of CNP mutants (Fig 8), which may directly hinder transcellular support processes. Swollen 
inner tongues as found in the CNS (Edgar et al., 2009) have almost never been seen in 
peripheral nerves of both genotypes. Swollen inner tongues potentially develop when the 
whole transport system within the glial cell collapses and no recirculation can take place 
causing an accumulation of material in distal glial regions (inner tongue). Theoretically this 
could happen in SC as well if peripheral nerves would reach the same level of degeneration 
as observed in the CNS. Contrary to the CNS, the ablation of CNP moreover has an impact 
on the size of the compact myelin compartment within peripheral nerves. CNP deficiency 
causes an adult onset hypermyelination. The myelin sheath thickness was normal during 
development and just slightly increased in juvenile stages, whereas additional 
ultrastructurally normal compact myelin wraps are accumulated during adulthood. 
Interestingly, the hypermyelination is more pronounced for small caliber axons. Hence, the 
magnitude of hypermyelination is indirectly proportional to axonal diameters and independent 
on motor and sensory characteristics of the axon (Fig 11). These data suggest that CNP is 
involved in adult negative regulation of myelination. As proposed by Snaidero and coworkers 
(2014), also in the PNS CNP may act as a physical spacer between neighbouring myelin 
layers and consequently when the spacer is ablated noncompact areas are further zipped 
and therefore reduced. Especially in the inner tongue ongoing addition of newly synthesized 
myelin components may not be blocked when the CNP-brake is released and thus allows for 
ongoing myelination. Together, the findings, that SC of small caliber axons express the most 
CNP and that they show the strongest hypermyelination when CNP is ablated led to the 
assumption, that the more CNP a SC expresses the more it relies on its myelin regulatory 
function. Contrary to other hypermyelinating mutants, CNP deficiency did not enhance the 
formation of tomacula or myelin inclusions, outfoldings or pathological alterations of Remak 
bundles (Fig 12) as described for the ablation of PMP22, PTEN or DLG1 (Adlkofer et al., 
1995; Goebbels et al., 2010, 2012; Cotter et al., 2010). This suggests different underlying 
mechanisms that all provoke excess myelin growth with distinct characteristic phenotypes.  
  
5.4 Molecular alterations upon CNP deficiency 
Even though CNP is one of the earliest markers within the SC lineage, its relative mRNA 
expression profile resembles that of other myelin genes like PLP and MBP (Scherer et al., 
1994). Interestingly, mRNA profiling studies with CNP overexpressing mutants revealed an 
earlier peak in myelin gene expression patterns (Gravel et al., 1996; Yin et al., 1997). 
Therefore we hypothesized, that the ablation of CNP may also interfere with regulatory 
mechanisms on transcriptional level and thus may shift the peak of myelin gene expression 
out of the critical window, possibly prolonging the myelination up to adult stages. Contrary to 
our expectations, quantitative mRNA analyses provided no evidence of altered myelin gene 
specific transcript levels for PLP, P0, MBP or MAG at any tested time point (Fig 13). 
Therefore we concluded that the deficiency of CNP does not impair myelination control on 
transcriptional level in peripheral nerves. This further imposed, that the adult onset 
hypermyelination of small caliber axons likely arose by changes in translational control or by 
altered lipid and myelin protein stability. Myelination is generally promoted by active 
PI3K/AKT and MAPK/ERK signaling during development (Taveggia et al., 2005; Maurel and 
Salzer, 2000; Pereira et al., 2012; Newbern et al., 2011; Ishii et al., 2013; Sheean et al., 
2014). Activity states of the pathways generally correspond to the level of phosphorylated 
(active) signaling molecules. In order to finish myelination, active promyelinating pathways 
have to be down regulated. This is mediated by a decrease of PI3K/AKT and MAPK/ERK 
pathway members and especially a down regulation of the phosphorylated isoforms. 
Additionally the activity of the translational machinery will be decreased (Sheean et al., 
2014). This finally slows myelin protein and lipid production to reach a steady state level to 
maintain the established myelin sheath throughout life. Both above mentioned pathways can 
influence myelination in either direction. Thus, negatively regulated PI3K/AKT signaling as 
described for conditional ablation of PTEN, DLG1 or DDIT4/REDD1/RTP801 induces 
hypermyelination (Noseda et al., 2013; Goebbels et al., 2010; Cotter et al., 2010; Macklin, 
2010). In contrast, constitutive activation of PI3K/AKT signaling has either no effect on 
peripheral myelination (PLP-AKT-DD, Flores et al., 2008), or even causes hypomyelination 
(EGR2-PI3K-DA, Sheean et al., 2014). On the other hand, hypermyelination of peripheral 
axons can be provoked by constitutive activation of ERK signaling in SC (from precursor 
stage on), which drives continued myelin growth (Ishii et al., 2013; Sheean et al., 2014). In 
contrast, acute activation of ERK signaling post maturation (P0-RafTR mutants or in vitro) 
leads to peripheral nerve demyelination (Napoli et al., 2012; Harrisingh et al., 2004). 
Therefore, only a coordinated regulation of both pathways ensures a matched myelin sheath 
synthesis for each axon. Interestingly, adult dorsal root preparations of CNP deficient 
animals displayed an increased activity for both pathways (Fig 14) compared to wildtype 
dorsal roots. The balanced upregulation of MAPK/ERK and PI3K/AKT signaling may abolish 
demyelinating effects as expected for pure increased AKT signaling or reactivated ERK 
signaling. Therefore, these alterations more likely resemble ongoing myelination as found in 
development. This suggests, that CNP is involved in the negative regulation of myelination 
when SC mature. Even though no general upregulation of the translational machinery, as 
described for MEK1DD mutants (Sheean et al., 2014) has been found in CNP deficient 
peripheral nerves, some myelin proteins (MBP and MyP2) and lipid related genes (HmgCR; 
SCAP) are elevated upon CNP deficiency (Fig 15). These findings additionally point to an 
ongoing myelination but moreover indicate an altered myelin stoichiometry in CNP deficient 
nerves. How CNP function influences the activity of the PI3K/AKT and MAPK/ERK signaling 
pathways can only be speculated. Schwann cells are equipped with A2a adenosine receptors 
and the PNS may also express the extracellular adenosine pathway as described for the 
brain (Stevens et al., 2004; Stone et al., 2009; Verrier et al., 2012, 2013). Here, CNP as 
catalytic enzyme may come into play. It can hydrolyze and therefore detoxify 2’,3’-cyclic 
nucleotides, that are found during RNA breakdown. Generated 2’-phosphonucleotides will 
further be degraded to their respective nucleotides. Here, for example adenosine can on its 
own promote axonal support and neuronal survival (Thompson et al., 1994; Jackson et al., 
2009). Hence, deletion of CNP would cause accumulation of 2’,3’-cyclic nucleotides and 
theoretically increased levels of their appropriate 3’,5’-cyclic isomers. Elevated 3’,5’-cyclic 
AMP (cAMP) level have been shown to promote Schwann cell differentiation and myelin 
gene expression via ERK1/2 activation (Arthur-Farraj et al., 2011; Stevens et al., 2004). This 
provides a possible link of the catalytic function of CNP and the observed elevated signaling 
pathways in adult CNP deficient peripheral nerves that potentially drives hypermyelination.  
 
5.5 CNP deficiency impairs small fiber integrity 
Up to the present, all discussed observations only referred to the integrity of SC. The 
observation, that CNP deficiency causes a severe neurodegeneration without a myelination 
defect (in the CNS) led to the assumption, that glial cells have supportive functions 
independent of myelination and that CNP may be directly involved in the axonal support 
(Lappe-Siefke et al., 2003; Nave and Trapp, 2008; Edgar and Nave, 2009; Nave, 2010a). 
CNP may have a similar direct supportive function within the PNS. Investigations of the 
axonal integrity in peripheral nerves revealed an adult onset loss of myelinated fibers, which 
is pronounced in sensory nerves (Fig 16, 17). However, a loss of myelinating and 
nonmyelinating SC has not been observed. A direct comparison to the CNS, which displays 
severe white matter atrophy upon CNP deficiency, reveals that the magnitude of 
degeneration is markedly lower within the PNS (Lappe-Siefke et al., 2003; Edgar et al., 
2009). The discrepancy might at least partially be explained by the ten times lower 
expression level of CNP in the PNS compared to the CNS (Kurihara and Tsukada, 1967). 
However, the predominance of fiber loss to small caliber axons has been reported for small 
caliber central nervous system fibers as well (Edgar et al., 2009) and therefore suggests a 
common function of CNP in axonal support for small caliber central and peripheral nerve 
fibers. How exactly CNP performs its supportive function is not yet clear. CNP is supposed to 
be involved in the structural maintenance of the noncompact myelin network by stabilizing 
membrane-cytoskeleton interactions (Bifulco et al., 2002; Lee et al., 2005). Ablating the 
structural functionality of CNP caused the bidirectional impairment of the compartments, with 
a reduction of the noncompact transport routes and an additional increase of the compact 
myelin which further elongated transport routes (Fig 8–11). A deterioration of the axonal 
support due to defective SC intrinsic and transcellular transport through the constricted axon-
SC interface can only be speculated. Therefore, we cannot exclusively answer the question if 
axonal loss is only caused by a trophic or metabolic undersupply due to the lack of CNP’s 
structural function or if the perspective function might be more direct as in the CNS, where 
imbalance of the compartments has not been observed. However, the pronounced sensory 
axonal loss and hypermyelination can further be correlated with an impaired peripheral nerve 
functionality, which is reflected in a hyposensitivity for mechanical and thermal stimulations in 
adult CNP deficient animals (Fig 19-21). Taken together, Schwann cells of small caliber 
axons that would normally express most CNP seem to rely most on its function. Hence, the 
ablation of CNP primarily impairs sensory SC integrity, which secondarily leads to a loss of 
small caliber peripheral axons, deteriorating peripheral nerve integrity and functionality. Thus 
the noncompact myelin protein CNP is of particular importance for the integrity of small 
peripheral nerve fibers.  
  
5.6 Model of CNP deficiency 
Within this work it has been shown, that SC exhibit different molecular compositions of their 
myelin sheaths according to the caliber of the engulfed axon. This led to the notion that 
myelinating SC are diverse and that they may individually adapt to the underlying axon. 
Here, CNP was found as one of the most differentially expressed proteins between SC types. 
Thus, SC of small caliber axons express most CNP and may therefore rely most on its 
function, making them more vulnerable to pathological alterations when CNP is ablated. The 
deficiency of CNP causes a remarkable hypermyelination of small caliber axons, which 
suggests an involvement of CNP in negative regulation of adult peripheral myelination likely 
through suppression of active signaling pathways. Moreover, loss of CNP as spacer causes 
a reduction of the noncompact myelin compartment which may by itself facilitate ongoing 
growth of the compact myelin sheath in small caliber axons. The imbalance of the 
compartments and the altered myelin stoichiometry likely deteriorate innermyelinic and 
transcellular transport processes. Alterations within SC may thus secondarily impair axonal 
support especially for small fibers which are finally lost. In contrast to normal appearing CNS 
myelin, ablation of CNP provokes a specific adult onset PNS phenotype that includes 
alterations within the myelin sheath and impaired axonal integrity. We propose that CNP 
serves discrete but partially overlapping functions in SC and oligodendrocytes. In summary, 
SC exhibit diverse molecular architectures of their myelin sheaths and the differentially 
expressed protein CNP is particularly important for the integrity of small myelinated fibers in 












Fig 22: Model of SC diversity and the differential impact of CNP on distinct PNS fibers 
The heterogeneous peripheral axons are associated with molecularly diverse SC. Different SC are equipped with 
a discrete myelin stoichiometry with CNP being enriched in SC surrounding small caliber axons. CNP acts as a 
brake for ongoing adult myelination and is thus involved in myelin sheath homeostasis. Moreover, SC exhibit 
trophic and metabolic support functions that likely depend on the integrity of the noncompact myelin compartment. 
When CNP is ablated, the myelin stoichiometry and the balance of compact and noncompact myelin are altered, 
especially in SC around small caliber axons. Therefore axonal support may be hampered leading to loss of small 
caliber axons during adulthood, which finally impairs sensation. 
5.7 Future directions 
In this work it has been shown that the composition of myelin sheaths surrounding small 
compared to large caliber axons differs. This led to the suggestion that myelinating SC are 
diverse. We hypothesize, that differences in myelin constitution resemble adaptations of SC 
to meet their own demands regarding the wide range of sheath dimensions, and to cope with 
individual requirements of discrete axonal subpopulation. In the past few years the number of 
known myelin proteins tremendously increased as mass spectrometry based myelin 
proteome analyses identified a broad spectrum of know but also unknown proteins as 
constituents of the myelin sheath (Jahn et al., 2009; Patzig et al., 2011; Monasterio-Schrader 
et al., 2012). In light of this, we initiated a second more in depth proteome analysis with more 
sensitive instrumentation to compare the molecular constitution of dorsal and ventral root 
myelin. This will allow for detection of less abundant differentially regulated myelin proteins 
and may moreover lead to the identification of myelin protein clusters that are essential for 
specific peripheral fiber types. Subsequent analysis of distinct fiber types in mouse models of 
further differentially expressed proteins will raise our understanding of specific tasks of 
myelin proteins for discrete fiber types.  
Furthermore these data are useful to better understand pathomechanisms of hereditary 
peripheral neuropathies that specifically affect motor or sensory fibers. For instance in 
Charcot-Marie-Tooth disease type 1A, the most common peripheral neuropathy (CMT1A - 
PMP22 duplication), pathological alterations differ with respect to the fiber type with 
progressive demyelination in large and hypermyelination of small fibers (Fledrich et al., 
2014). Upcoming analyses of CNP levels in the CMT rat model will evaluate an involvement 
of CNP in the general disease etiology.  
In relation to the specific PNS phenotype of CNP deficient nerves it would be highly 
interesting to analyze the direct consequences of imbalanced myelin compartments. We 
propose that the increase of compact and decrease of noncompact myelin hampers the 
innermyelinic transport and finally the axonal support. Neuronal expression of metabolic 
reporters (e.g. for glucose or lactate) in CNP mutant mice and investigation of their activity 
upon ex-vivo stimulation of the peripheral nerves could provide more direct evidence for 
hampered axonal support. Moreover ex-vivo recordings of dorsal and ventral roots of CNP 
deficient compared to wildtype animals may give direct insight in the differential impairment 
of motor and sensory nerves upon CNP deficiency.  
Furthermore, the exciting question of how CNP influences activity of MAPK/ERK and 
PI3K/AKT signaling remained unanswered. 3’5’-cAMP is reported to be promyelinating and 
has influence on the two pathways (Stevens et al., 2004; Monje et al., 2008). Therefore the 
catalytic activity of CNP may have an impact on the signaling activities. 2’,3’-cAMP and 3’,5’-
cAMP are positional isomers (Jackson et al., 2009) and thus the increase of 2’,3’-cAMP 
when CNP is non-functional may also influence 3’,5’-cAMP levels, which may directly 
activate the above mentioned signaling cascades and thus influence myelination. To this 
end, direct analysis of 3’,5’-cAMP (and 2’,3’-cAMP) level could help to unravel the link 
between CNP and the signaling pathways. Simultaneously this would show the importance of 
the CNP catalytic activity for small fiber integrity within the peripheral nervous system. 
Our new observations together with potential future findings may contribute to our 
understanding of peripheral nerve myelination and axonal support and advance our 
knowledge about the etiology of peripheral neuropathies.  
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